Christine B. Peterson, PhD
Department of Biostatistics, Division of Discovery Science
About Dr. Peterson
Selected publications are listed below; for a full list, please see Google scholar profile. For more information, including links to papers and software, please see Dr. Peterson's website at https://odin.mdacc.tmc.edu/~cbpeterson/.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Biostatistics, Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Associate Professor, Department of Biostatistics, UTHealth Houston School of Public Health, Houston, Texas
Adjunct Associate Professor, Department of Statistics, Rice University, Houston, Texas
Education & Training
Degree-Granting Education
| 2013 | Rice University, Houston, Texas, US, PhD in Statistics |
| 2005 | Harvard University, Cambridge, Massachusetts, US, AB in Applied Mathematics |
Postgraduate Training
| 2014-2016 | Postdoctoral Scholar, Stanford University, Stanford, California |
Experience & Service
Faculty Academic Appointments
Adjunct Assistant Professor, Department of Statistics, Rice University, Houston, Texas, 2018 - 2022
Assistant Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - 2022
Other Professional Positions
Software Design Engineer, Microsoft, Redmond, WA, 2005 - 2009
Institutional Committee Activities
Committee member, Institute for Data Science in Oncology (IDSO) Internal Advisory Council, 2024 - Present
Committee member, Biostatistics Faculty Search Committee, 2022 - 2023
Committee member, Institutional Review Board (IRB), 2019 - Present
Committee member, Biostatistics Faculty Search Committee, 2018 - 2019
Member, Medical Physics Program Steering Committee, 2017 - 2020
Honors & Awards
| 2024 | Andrew Sabin Family Foundation Award, Andrew Sabin Family Foundation |
| 2020 | Nominee, Robert M. Chamberlain Distinguished Mentor, MD Anderson Postdoctoral Association |
| 2015 | Savage Award (Best dissertation in Applied Methodology), International Society for Bayesian Analysis (ISBA) |
| 2014 | Postdoctoral fellowship, Center for Evolutionary, Computational and Human Genetics (CEHG), Stanford University |
| 2014 | Student paper competition award, Section on Bayesian Statistical Science (SBSS) |
| 2012 | Best presentation award, NLM Informatics Training Conference |
| 2011 | Predoctoral fellowship, National Library of Medicine (NLM) Biomedical Informatics Research Training Program |
| 2009 | Predoctoral fellowship, T32 Training Grant in Biostatistics for Cancer Research, National Cancer Institute (NCI) |
| 2009 | President's Graduate Fellowship, Rice University |
| 2005 | Phi Beta Kappa, Harvard University |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2025. Flexible feature aggregation for microbiome analysis. Invited. Conference of Texas Statisticians (COTS). Woodlands, TX, US.
- 2024. Tree-aggregated factor regression for microbiome data integration. Invited. Texas A&M Bioinformatics Symposium. College Station, TX, US.
National Presentations
- 2025. Flexible feature aggregation for microbiome analysis. Invited. Conference on Statistics in Genomics and Genetics (STATGEN). Minneapolis, MN, US.
- 2024. Sparse Bayesian regression with varying effects for microbiome association. Invited. Joint Statistical Meetings. Portland, OR, US.
- 2024. Bayesian selection of network-linked predictors with covariate-driven effects. Conference. ENAR Spring Meeting. Baltimore, Maryland, US.
- 2023. Tree-aggregated factor regression for microbiome data integration. Conference. ICSA Applied Statistics Symposium. Ann Arbor, MI, US.
- 2023. Bayesian learning of multiple non-linear dependence networks. Conference. New England Statistics Symposium. Boston, MA, US.
- 2022. Bayesian sparse modeling to identify high-risk subgroups. Conference. Joint Statistical Meetings. Washington, DC, US.
- 2022. Identifying covariate-driven connections in directed networks. Conference. ENAR Spring Meeting. Houston, TX, US.
- 2021. Scalable Bayesian inference of networks and covariate effects. Conference. Joint Statistical Meetings, US.
- 2020. Flexible and informative clustering of microbiome data. Conference. ICSA Applied Statistics Symposium. Houston, TX, US.
- 2020. Efficient Bayesian estimation of microbiome association networks. Conference. Joint Statistical Meetings. Philadelphia, PA, US.
- 2020. Bayesian modeling of multiple structural connectivity networks during the progression of Alzheimer’s disease. Conference. ENAR Spring Meeting. Nashville, TN, US.
- 2019. A Bayesian classification model for radiomics data. Conference. WNAR Annual Meeting. Portland, OR, US.
- 2018. Bioinformatics tools to gain insight into proteomic and genomic data. Conference. International VHL Medical/Research Symposium. Houston, TX, US.
- 2018. Bayesian hierarchical modeling for inference of multiple graphical models. Conference. ENAR Spring Meeting. Atlanta, GA, US.
- 2016. Bayesian multivariate modeling of pathways underlying disease severity in COPD. Conference. ENAR Spring Meeting. Austin, TX, US.
- 2015. Savage Award winner: Approaches in Bayesian graphical modeling. Conference. Joint Statistical Meetings. Seattle, WA, US.
- 2014. Bayesian inference of multiple Gaussian graphical models. Conference. Joint Statistical Meetings. Boston, MA, US.
- 2014. Bayesian inference of multiple Gaussian graphical models. Conference. Joint Applied Statistics Symposium. Portland, OR, US.
- 2013. Bayesian inference of multiple Gaussian graphical models. Conference. ENAR Spring Meeting. Orlando, FL, US.
- 2012. Inferring biological networks using the Bayesian graphical lasso with informative priors. Conference. Joint Statistical Meetings. San Diego, CA, US.
- 2012. Inferring biological networks using the Bayesian graphical lasso. Conference. NLM Informatics Training Conference. Madison, WI, US.
International Presentations
- 2024. Joint Bayesian additive regression trees for inference of multiple non-linear dependence networks. Invited. CFE-CMStatistics. London, GB.
- 2013. Bayesian inference of multiple Gaussian graphical models. Conference. Bayesian inference of multiple Gaussian graphical models. Montreal, CA.
Formal Peers
- 2024. New methods for microbiome data integration. Austin, TX, US.
- 2023. New methods for microbiome data integration. Invited. Richmond, VA, US.
- 2023. Meta-analysis of safety data. Invited. Jackson, MS, US.
- 2023. New methods for microbiome data integration. Invited. Dallas, TX, US.
- 2022. New approaches for integrating microbiome and covariate data. Invited. Cleveland, OH, US.
- 2022. New approaches for integrating microbiome and covariate data. Invited. Stanford, CA, US.
- 2021. New approaches for integrating microbiome and covariate data. Invited. Philadelphia, PA, US.
- 2021. Visualization and feature selection for microbiome data. Invited. Columbus, OH, US.
- 2021. New approaches for visualization and clustering of microbiome data. Invited. Houston, TX, US.
- 2020. New approaches for visualization and clustering of microbiome data. Invited. Ann Arbor, MI, US.
- 2020. Bayesian variable selection for microbiome data. Invited. College Station, TX, US.
- 2019. Flexible and informative clustering of microbiome data. Invited. Houston, TX, US.
- 2017. Integrative network analysis using Bayesian graphical models. Invited. Seattle, WA, US.
- 2016. Bayesian inference of multiple Gaussian graphical models. Invited. Cambridge, MA, US.
Grant & Contract Support
| Date: | 2026 - 2027 |
| Title: | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | #TBA |
| Date: | 2026 - 2031 |
| Title: | Innovative approaches for deeper insights into microbiome data |
| Funding Source: | Cornell University |
| Role: | Non |
| ID: | #TBA |
| Date: | 2025 - 2030 |
| Title: | Surgical De-escalation in Gynecologic Cancers: A Patient-Centered Multidimensional Analysis |
| Funding Source: | NIH |
| Role: | Other |
| ID: | #TBA |
| Date: | 2025 - 2030 |
| Title: | IGNITE-TX |
| Funding Source: | NIH |
| Role: | Other |
| ID: | #TBA |
| Date: | 2025 - 2030 |
| Title: | Training Program in Biostatistics for Cancer Research |
| Funding Source: | RICE University |
| Role: | Mentor |
| ID: | #TBA |
| Date: | 2025 - 2027 |
| Title: | New statistical approaches to characterize the role of the microbiome in CAR T-cell therapy toxicities |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | #TBA |
| Date: | 2025 - 2028 |
| Title: | 230355: Collaborative Research: Leveraging network and community structures in predictive modeling |
| Funding Source: | NSF |
| Role: | Other |
| ID: | #TBA |
| Date: | 2025 - 2027 |
| Title: | New methods for network-guided varying-effects regression with application to microbiome association studies |
| Funding Source: | NIH |
| Role: | PD/PI |
| ID: | #TBA |
| Date: | 2025 - 2025 |
| Title: | Enhancing clinical trial credentialing to improve radiotherapy data quality |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | #TBA |
| Date: | 2025 - 2029 |
| Title: | Bile acids as a mediator of the diet-microbiome-immune axis |
| Funding Source: | V FOUNDATION |
| Role: | Co-I |
| ID: | #TBA |
| Date: | 2025 - 2026 |
| Title: | Harnessing tertiary lymphoid structure function for improved immunotherapeutic strategies in cancer patients |
| Funding Source: | UPMC |
| Role: | Co-I |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Developing Automated tools for Cervical Cancer Radiotherapy Treatment for Zambian Women living with HIV (Biospecimen/Cohort) - 48S4 |
| Funding Source: | NCI |
| Role: | Other |
| ID: | #TBA |
| Date: | 2024 - 2026 |
| Title: | Meta-analysis of Adverse Drug Effects in Clinical Trials |
| Funding Source: | PENN STATE UNIV |
| Role: | PD/PI |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Clinical Testing of a Magnetic Imaging Workflow for Sentinel Lymph Node Biopsy in Head and Neck Cancer |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Targeting the gut microbiome to inhibit melanoma lymph node metastases |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | Biostatistician |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Translation of gut commensal bacteria peptidoglycan remodeling pathway for chimeric antigen receptor T-cell therapy |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Toward clinical monitoring of tumor stromal dynamics using integrated quantitative ultrasound applications |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | Biostatistician |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | Targeting mucin degradation to prevent neutropenic fever after HCT conditioning |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2029 |
| Title: | A Novel Transplant Conditioning Regimen to Enhance Anti-leukemia Immunity |
| Funding Source: | NIH |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2027 |
| Title: | Decoding target delineation from multi-modal images: a prospective investigation for oropharyngeal cancer radiotherapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2027 |
| Title: | Optimization of dose fractionation to enhance immuno-stimulating effect of proton beam therapy, with and without immunotherapy, to improve treatment outcomes |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2027 |
| Title: | Translation of gut commensal bacteria peptidoglycan remodeling pathway for chimeric antigen receptor T-cell therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2024 - 2027 |
| Title: | Addressing hurdles to AI-based radiotherapy treatment planning |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2023 - 2025 |
| Title: | Validation Of Quantitative MRI As A Biomarker Of Tumor Response And Oncologic Outcomes In Head And Neck Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | Biostatistician |
| ID: | 1R21DE032783-01A1 |
| Date: | 2023 - 2028 |
| Title: | Prebiotic dietary intervention in melanoma patients on immunotherapy |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2023 - 2028 |
| Title: | Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 2R01CA219896-06 |
| Date: | 2023 - 2026 |
| Title: | Evidence-integration strategies and tools for assessment of comparative medication safety |
| Funding Source: | NIH Subaward via PENN STATE UNIVERSITY |
| Role: | CO-I |
| ID: | TBA |
| Date: | 2023 - 2028 |
| Title: | OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVivorship |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1P01CA285249-01 |
| Date: | 2023 - 2028 |
| Title: | Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 1P01HL170046-01 |
| Date: | 2023 - 2028 |
| Title: | Targeting mucin degradation to prevent neutropenic fever after HCT conditioning |
| Funding Source: | NIH/NIAID |
| Role: | CO-I |
| ID: | 1R01AI178677-01 |
| Date: | 2023 - 2028 |
| Title: | Development of treatment strategies for antibiotic-induced graft-versus-host disease |
| Funding Source: | NIH/NCI |
| Role: | Specify |
| ID: | 1K99AI175968-01A1 |
| Date: | 2023 - 2025 |
| Title: | Statistical Methods for Meta-analysis of Safety Data |
| Funding Source: | NIH/NLM Subaward-Subcontract via Penn State University |
| Role: | Multiple PI |
| ID: | 1R21LM014185-01A1 |
| Date: | 2023 - 2028 |
| Title: | Improving the dosimetric quality of radiation therapy and incorporating its impact into clinical trial design |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA282142-01 |
| Date: | 2023 - 2028 |
| Title: | Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE032521-01A1 |
| Date: | 2023 - 2025 |
| Title: | Co-Targeting Androgen Receptor Signaling and DNA Damage Response in BRCA1/2-Mutant Prostate Cancer |
| Funding Source: | BRCA Research & Cure Alliance |
| Role: | Biostatistician |
| ID: | #TBA |
| Date: | 2023 - 2025 |
| Title: | Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD) |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R21CA273984-01A1 |
| Date: | 2023 - 2028 |
| Title: | Prebiotic dietary intervention in melanoma patients on immunotherapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA278901-01 |
| Date: | 2023 - 2028 |
| Title: | InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery - Core D: The Biostatistics Core |
| Funding Source: | NIH/NCI |
| Role: | Core Leader |
| ID: | 1P01CA278716-01 |
| Date: | 2023 - 2025 |
| Title: | Statistical Methods for Meta-analysis of Safety Data |
| Funding Source: | NIH/NLM Subaward Via University of Pennsylvania |
| Role: | MPI |
| ID: | 1R21LM014185-01A1 |
| Date: | 2023 - 2028 |
| Title: | IGNITE-TX (Increase Genetic Hereditary Cancer Testing in Texas) |
| Funding Source: | Patient-Centered Outcomes Res Inst PCORI |
| Role: | Statistician |
| ID: | FP00016207 |
| Date: | 2023 - 2028 |
| Title: | IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer): A Randomized, Controlled Trial |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Statistician |
| ID: | RP230126 |
| Date: | 2023 - 2028 |
| Title: | Targeting the mucus degrading microbiome in acute radiation syndrome |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1U01AI173740-01 |
| Date: | 2022 - 2027 |
| Title: | Transforming Brain Tumor Management: "Preoperative Stereotactic Radiosurgery (SRS) Versus Postoperative SRS for Brain Metastases" |
| Funding Source: | NIH/NCI |
| Role: | Co- Mentor |
| ID: | #TBA |
| Date: | 2022 - 2027 |
| Title: | Metabolic imaging of patients with anaplastic thyroid cancer using hyperpolarized [1-13C]-pyruvate |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2022 - 2027 |
| Title: | Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA280980-01A1 |
| Date: | 2022 - 2027 |
| Title: | Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01DE032521-01 |
| Date: | 2022 - 2027 |
| Title: | Spatiotemporal Tumor-Immune Co-Evolution that Models Early Lung Adenocarcinoma Development |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1U01CA264583-01A1 |
| Date: | 2022 - 2025 |
| Title: | Developing a Data and Tissue-Sharing Platform for Von Hippel Lindau Disease |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | RA210205 |
| Date: | 2022 - 2027 |
| Title: | Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1U01CA264583-01A1 |
| Date: | 2022 - 2027 |
| Title: | Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA273339-01 |
| Date: | 2022 - 2027 |
| Title: | ROAR C2 - Reduction of Toxicity Using Online Adaptive Radiotherapy for Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA275186-01 |
| Date: | 2022 - 2023 |
| Title: | FLAP: Functional outcomes by oraL defect: needs Assessment and Patient-reported outcomes |
| Funding Source: | AMERICAN ACADEMY OF OTOLARYNGOLOGY |
| Role: | Statistician |
| ID: | #TBA |
| Date: | 2022 - 2026 |
| Title: | New data science approaches to visualize and understand the impact of the microbiome on risk of graft-versus-host disease |
| Funding Source: | NIH/NHLBI |
| Role: | PD/PI |
| ID: | 51R01HL158796-02 |
| Date: | 2022 - 2027 |
| Title: | Microbiome and febrile neutropenia in patients with hematological malignancies |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 1R01HL162781-01 |
| Date: | 2022 - 2024 |
| Title: | Quantitative Magnetic Resonance Imaging for Assessment of Treatment Response and Disease Control in Head and Neck Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R21DE031048-01A1 |
| Date: | 2022 - 2027 |
| Title: | Microbiome and epithelial regeneration following therapy for GVHD |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 1R01HL162802-01 |
| Date: | 2022 - 2027 |
| Title: | Metabolic imaging of patients with anaplastic thyroid cancer using hyperpolarized [1-13C]-pyruvate |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA269827-01 |
| Date: | 2022 - 2027 |
| Title: | Molecular and Therapeutic Evaluation of miR-27a* in Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE031161-01A1 |
| Date: | 2022 - 2024 |
| Title: | Innovating Spine Radiosurgery by MR-Guided Linear Accelerators |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R21CA263103-01A1 |
| Date: | 2022 - 2027 |
| Title: | Online Adaptive Radiotherapy to Reduce Toxicity in Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NIBIB |
| Role: | CO-I |
| ID: | 1R01CA267646-01A1 |
| Date: | 2022 - 2027 |
| Title: | INFORM: Image-based machiNe learning For OsteoRadionecrosis prediction and Management in head and neck Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE031945-01 |
| Date: | 2022 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | |
| Role: |
| Date: | 2022 - 2025 |
| Title: | Single-Cell Decoding of Spatiotemporal and Ecological Evolution in Early-Stage KRAS-Mutant Lung Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP220101 |
| Date: | 2022 - 2025 |
| Title: | An innovative approach to improve the accuracy and consistency of hadrontherapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | #TBA |
| Date: | 2022 - 2026 |
| Title: | Optimizing Precision Oncology Approaches With Hyperpolarized MRI in Head and Neck Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | #TBA |
| Date: | 2022 - 2025 |
| Title: | Quantitative Magnetic Resonance Imaging for Assessment of Treatment Response and Disease Control in Head and Neck Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Biostatistician |
| ID: | RP220173 |
| Date: | 2022 - 2025 |
| Title: | Fucosylated TIL for the treatment of metastatic melanoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Statistician |
| ID: | #TBA |
| Date: | 2022 - 2025 |
| Title: | New data science approaches to visualize and understand the impact of the microbiome on cancer treatment outcomes |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP220066 |
| Date: | 2022 - 2025 |
| Title: | An international, multicenter study to investigate and validate microbiome configurations and effectors in CD19-targeted CAR-T cell efficacy and toxicity |
| Funding Source: | Mark Foundation for Cancer Research |
| Role: | CO-I |
| ID: | AWD00006436 |
| Date: | 2022 - 2025 |
| Title: | Multiparametric Magnetic Resonance Imaging Artificial Intelligence Pipeline for Oropharyngeal Cancer Radiotherapy Treatment Guidance |
| Funding Source: | NIH/NIDCR |
| Role: | Other Significant Contributor |
| ID: | 1F31DE031502-01 |
| Date: | 2021 - 2023 |
| Title: | A non-invasive metabolomics-based lipid signature in localized prostate cancer patients: dietary and surgical effects |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R03CA255988-01A1 |
| Date: | 2021 - 2023 |
| Title: | Targeting Breast Cancer Stem Cells |
| Funding Source: | BREAST CANCER RESEARCH FOUNDATION |
| Role: | CO-I |
| ID: | BCRF-21-007 |
| Date: | 2021 - 2024 |
| Title: | Targeting the DNA damage repair network to promote an innate immune response in ccRCC |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | KC200150 |
| Date: | 2021 - 2026 |
| Title: | Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE031351-01 |
| Date: | 2021 - 2026 |
| Title: | InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery |
| Funding Source: | NIH/NCI |
| Role: | Core Leader |
| ID: | 1P01CA254866-01A1 |
| Date: | 2021 - 2026 |
| Title: | Investigating ALK2 as a Biomarker and Therapeutic Target in FLT3-ITD Positive Acute Myeloid Leukemia |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 1R01CA266483-01 |
| Date: | 2021 - 2024 |
| Title: | Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events |
| Funding Source: | NIH/NINR |
| Role: | CO-I |
| ID: | 1R01NR019778-01A1 |
| Date: | 2021 - 2026 |
| Title: | Oropharyngeal and Orodental Cancer PatienT Image-guidance by MRI for Assessment of Toxicity and Oncologic Outcomes of Radiotherapy (O2PTIMATO2R) |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE031441-01 |
| Date: | 2021 - 2026 |
| Title: | Online Adaptive Radiotherapy to Reduce Toxicity in Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA267646-01 |
| Date: | 2021 - 2026 |
| Title: | Diet and the gut microbiome in hepatocellular carcinoma patients initiating immunotherapy: new targets to improve clinical outcomes |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1-R01-CA266267-01 |
| Date: | 2021 - 2024 |
| Title: | An innovative approach to improve the accuracy and consistency of hadrontherapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA266101-01 |
| Date: | 2021 - 2025 |
| Title: | Modeling of radiotherapy contouring and treatment planning for virtual clinical trials |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA266370-01 |
| Date: | 2021 - 2024 |
| Title: | Collaborative research: Covariate-driven approaches to network estimation |
| Funding Source: | National Science Foundation (NSF) |
| Role: | PD/PI |
| ID: | 2113557 |
| Date: | 2021 - 2025 |
| Title: | Evaluating Angiogenesis, DNA Repair and Immune Pathways in VHL Disease Related Brain, Pancreatic and Adrenal Tumors |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | CA201116 |
| Date: | 2021 - 2025 |
| Title: | New data science approaches to visualize and understand the impact of the microbiome on risk of graft-versus-host disease |
| Funding Source: | NIH/NHLBI |
| Role: | PD/PI |
| ID: | 1R01HL158796-01 |
| Date: | 2021 - 2024 |
| Title: | Doris Duke-Gregg |
| Funding Source: | Doris Duke Charitable Foundation |
| Role: | Mentor |
| ID: | #TBA |
| Date: | 2021 - 2026 |
| Title: | Molecular and Therapeutic Evaluation of miR-27a* in Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE031161-01 |
| Date: | 2021 - 2026 |
| Title: | Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1U01CA264583-01 |
| Date: | 2021 - 2024 |
| Title: | Developing a data and tissue sharing platform for von Hippel Lindau disease |
| Funding Source: | DOD Rare Cancers Research Program / Resource and Community Development Award |
| Role: | CO-I |
| ID: | RA200394 |
| Date: | 2021 - 2023 |
| Title: | Quantitative Magnetic Resonance Imaging for Assessment of Treatment Response and Disease Control in Head and Neck Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R21DE031048-01 |
| Date: | 2021 - 2026 |
| Title: | Mechanistic probiotic/prebiotic strategies to protect colonic mucus and prevent neutropenic fever in cytotoxic cancer therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA263840-01 |
| Date: | 2021 - 2026 |
| Title: | Mechanisms and Targeting Bone Remodeling in Acute Myeloid Leukemia |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 1R01CA262089-01 |
| Date: | 2021 - 2026 |
| Title: | Spatiotemporal and ecological evolution in early stage KRAS-mutant lung cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA262076-01 |
| Date: | 2021 - 2026 |
| Title: | Statistical Approaches to Quantitative Imaging and Operations REsearch for CAncer Related Radiotherapy |
| Funding Source: | NIH/NIDCR |
| Role: | Other Significant Contributor |
| ID: | 1K02DE030525-01 |
| Date: | 2021 - 2026 |
| Title: | Online Adaptive Radiotherapy to Reduce Toxicity in Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA252889-01A1 |
| Date: | 2021 - 2026 |
| Title: | Novel Biomedical Imaging and Modeling for Prevention and Management of Osteoradionecrosis in Head and Neck Cancer Patients |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R01DE030587-01 |
| Date: | 2021 - 2026 |
| Title: | Radiation Dose-Volume Associations with Neurocognitive Change and Late Neurocognitive and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton Radiotherapy |
| Funding Source: | Subaward/Subcontract via Baylor College of Medicine |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2021 - 2024 |
| Title: | Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events |
| Funding Source: | NIH/NINR |
| Role: | CO-I |
| ID: | 1R01NR019778-01 |
| Date: | 2021 - 2026 |
| Title: | Dissecting the Sex Specific Immunomodulatory Phenotypes in the Pathogenesis of Kras Mutant Lung Adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA258098-01 |
| Date: | 2021 - 2025 |
| Title: | Bayesian Network-Based Integrative Genomics Methods for Precision Medicine |
| Funding Source: | NIH/NCI Subaward via Penn State University |
| Role: | CO-I |
| ID: | 5R01CA244845-03 |
| Date: | 2021 - 2023 |
| Title: | Blood-based MRPS30 autoantibodies for early detection of breast cancer |
| Funding Source: | Prevent Cancer Foundation (PCF) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2022 |
| Title: | A non-invasive metabolomics-based lipid signature in localized prostate cancer patients: dietary and surgical effects |
| Funding Source: | NIH/NCI |
| Role: | Significant Contributor |
| ID: | 1R03CA255988-01 |
| Date: | 2020 - 2025 |
| Title: | Advancing RBE models for high LET particles beyond the linear-quadratic model |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA256778-01 |
| Date: | 2020 - 2022 |
| Title: | Identification of SARS-Cov-2 Antigens and Markers of Infection in Extracellular Vesicles Isolated from Clinical Specimens Utilizing Optimized Mass Spectrometry Methods |
| Funding Source: | NIH/NCATS |
| Role: | CO-I |
| ID: | 1U18TR003819-01 |
| Date: | 2020 - 2021 |
| Title: | Targeting Breast Cancer Stem Cells |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Biostatistician |
| ID: | AWD00005233 |
| Date: | 2020 - 2022 |
| Title: | Prediction of immune-related adverse events during checkpoint inhibition using TCRB repertoire sequencing and patient-reported outcomes |
| Funding Source: | Gateway for Cancer Research |
| Role: | Biostatistician |
| ID: | #TBA |
| Date: | 2020 - 2023 |
| Title: | Kidney Cancer Clinical Trials Consortium |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | KC190010 |
| Date: | 2020 - 2025 |
| Title: | Late Neurocognitive and Functional Outcomes and Radiation Dose-Volume Associations with Neurocognitive Change in Pediatric Brain Tumor Patients Treated with Proton Radiotherapy |
| Funding Source: | Subaward-Baylor College of Medicine |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2024 |
| Title: | Targeting DNA Repair and Immune Pathways in VHL Disease Related Brain, Pancreatic and Adrenal Tumors |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2023 |
| Title: | Blood-based MRPS30 autoantibodies as a novel biomarker for early detection of hormone receptor-positive breast cancer |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2022 |
| Title: | Evaluation of diffusion-weighted-MRI as a biomarker of treatment response and disease control in Head and Neck Malignancies |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 1R21DE030192-01 |
| Date: | 2020 - 2025 |
| Title: | Real-time intraprocedural biomechanical imaging: integrating tissue mechanics into image-guided diagnosis and therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA256940-01 |
| Date: | 2020 - 2025 |
| Title: | InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery 665167 |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1P01CA254866-01 |
| Date: | 2020 - 2025 |
| Title: | Molecular Photoacoustic Imaging for Diagnostics and Therapy Monitoring |
| Funding Source: | NIH/NIBIB |
| Role: | CO-I |
| ID: | 5R01EB028762-03 |
| Date: | 2020 - 2025 |
| Title: | Next-Generation Translational Microbiome Center |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP200591 |
| Date: | 2020 - 2025 |
| Title: | Late Neurocognitive and Functional Outcomes and Radiation Dose-Volume Associations with Neurocognitive Change in Pediatric Brain Tumor Patients Treated with Proton Radiotherapy |
| Funding Source: | Baylor College of Medicine |
| Role: | CO-I |
| ID: | FP00008933 |
| Date: | 2020 - 2022 |
| Title: | Identifying Actionable Signatures of Duodenopancreatic Neuroendocrine Tumor Progression in MEN1 |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R21CA252426-01 |
| Date: | 2020 - 2023 |
| Title: | Targeting the Replication Stress Response to Induce Anti-Cancer Immunity in Advanced Solid Malignancies |
| Funding Source: | Conquer Cancer Foundation |
| Role: | Biostatistician |
| ID: | AWD00004826 |
| Date: | 2020 - 2025 |
| Title: | Clinical trial of microbiome optimization as prophylaxis for acute graft-versus-host disease |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01 CA251810-01 |
| Date: | 2020 - 2023 |
| Title: | Bayesian Statistical Approaches for Modeling Human Microbiome Dynamics |
| Funding Source: | NIH/NCI |
| Role: | Primary Mentor |
| ID: | 1K99GM138752-01 |
| Date: | 2020 - 2021 |
| Title: | The role of diet and the microbiome in inducing somatic mutations in colorectal epithelial cells and its predisposition to carcinogenesis |
| Funding Source: | American College of Gastroenterology |
| Role: | Collaborator |
| ID: | #TBA |
| Date: | 2020 - 2022 |
| Title: | Identifying Actionable Signatures of dpNET Progression in MEN1 |
| Funding Source: | American Association for Cancer Research (AACR) |
| Role: | Collaborator |
| ID: | 703445 |
| Date: | 2020 - 2025 |
| Title: | Online Adaptive Radiotherapy to Reduce Toxicity in Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA252889-01 |
| Date: | 2020 - 2025 |
| Title: | LoxL2 and H3K4 methylation as effectors of anti-PD1 response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA244997-01A1 |
| Date: | 2020 - 2025 |
| Title: | The comprehensive assessment of radiotherapy compliance in clinical trials: An automated web-based solution |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1U24CA253372-01 |
| Date: | 2020 - 2024 |
| Title: | SIV-Varian Strategic Alliance Project: Networked Plan QA & Review Platform |
| Funding Source: | Varian Medical System Foundation |
| Role: | CO-I |
| ID: | 57688 |
| Date: | 2020 - 2023 |
| Title: | Transforming the Standard of Care: A Personalized Approach for Patients with Cancer Metastatic to the Brain |
| Funding Source: | Brockman Foundation |
| Role: | CO-I |
| ID: | AWD00004716 |
| Date: | 2020 - 2022 |
| Title: | Image-Guided Radiation Therapy for Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R21CA248005-01 |
| Date: | 2020 - 2024 |
| Title: | Artificial intelligence for the peer review of radiation therapy treatments |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP200395 |
| Date: | 2020 - 2022 |
| Title: | Drug Repurposing Approach to Identify GD3 Synthase (ST8SIA1) Inhibitors and Target Breast Cancer-Stem-like Cells in Triple Negative Breast Cancer |
| Funding Source: | Emerson Collective |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2023 |
| Title: | Novel Combinatorial Strategies to Overcome Resistance to Current Therapies for Aggressive Thyroid Cancers |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | #TBA |
| Date: | 2020 - 2021 |
| Title: | Stop LCNP: High dose steroid therapy for late radiation-associated lower cranial neuropathy |
| Funding Source: | Health and Environmental Sciences Institute |
| Role: | Statistician |
| ID: | AWD00004455 |
| Date: | 2020 - 2022 |
| Title: | Adoptive transfer of TGF-ß resistant TIL to defeat immunosuppressive PDAC |
| Funding Source: | Stand Up To Cancer |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2020 - 2022 |
| Title: | Establishing the Efficacy of Salpingectomy through an International Trial |
| Funding Source: | University of Washington |
| Role: | CO-I |
| ID: | #TBA |
| Date: | 2019 - 2023 |
| Title: | Clinical trial of microbiome optimization as prophylaxis for acute graft-versus-host disease |
| Funding Source: | Food and Drug Administration (FDA) |
| Role: | CO-I |
| ID: | 1R01FD006838-01 |
| Date: | 2019 - 2022 |
| Title: | Dissecting the role of gut microbiome in early-stage non-small cell lung cancer evolution and responsiveness to immune checkpoint inhibitors |
| Funding Source: | Mark Foundation Cancer Research |
| Role: | Collaborator |
| ID: | FP00009032 |
| Date: | 2019 - 2023 |
| Title: | Rational Combinations to Target the Replication Stress Response in Prostate Cancer |
| Funding Source: | Prostate Cancer Foundation |
| Role: | CO-I |
| ID: | FP00007799 |
| Date: | 2019 - 2020 |
| Title: | Stop-LCNP: Steroid therapy for late radiation-associated lower cranial neuropathy |
| Funding Source: | MDACC Oropharynx Cancer Program |
| Role: | CO-I |
| ID: | 600382-80-122321-21 |
| Date: | 2019 - 2020 |
| Title: | Targeting Breast Cancer Stem Cells |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Biostatistician |
| ID: | BCRF-18-007 |
| Date: | 2019 - 2024 |
| Title: | Transforming the Standard of Care: A Personalized Approach for Patients with Cancer Metastatic to the Brain |
| Funding Source: | Brockman Foundation |
| Role: | CO-I |
| ID: | TBA/ FP00007917 |
| Date: | 2019 - 2021 |
| Title: | Targeting the Replication Stress Response in Advanced Prostate Cancer |
| Funding Source: | MDACC Career Enhancement Program |
| Role: | Biostatistician |
| ID: | 600655-80-122486-21 |
| Date: | 2019 - 2024 |
| Title: | Defining the Therapeutic Efficacy of miR-27a* in Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01DE028601-01A1 |
| Date: | 2019 - 2024 |
| Title: | LoxL2 and H3K4 methylation as effectors of anti-PD1 response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA244997-01 |
| Date: | 2019 - 2024 |
| Title: | Bayesian Network-Based Integrative Genomics Methods for Precision Medicine |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA244845-01 |
| Date: | 2019 - 2022 |
| Title: | Lipidomics-based Biomarkers and Therapy for Early Prostate Cancer in African Americans |
| Funding Source: | DOD Health Disparities Research Award |
| Role: | CO-I |
| ID: | TBA/ FP00006650 |
| Date: | 2019 - 2024 |
| Title: | Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA231471-01A1 |
| Date: | 2019 - 2024 |
| Title: | Patient-centered liver cancer prevention in the Houston community |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Statistical Faculty Collaborator |
| ID: | RP190513 |
| Date: | 2019 - 2024 |
| Title: | Cancer Center Support Grant (CCSG) - Biostatistics Resource Group (BRG) |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 5P30CA016672-46 |
| Date: | 2019 - 2022 |
| Title: | Targeting Immune Checkpoint protein B7-H3 (CD276) in Acute Myeloid Leukemia |
| Funding Source: | Leukemia and Lymphoma Society |
| Role: | CO-I |
| ID: | 6585-20 |
| Date: | 2019 - 2020 |
| Title: | Characterization of small molecule inhibitors for targeting GD3 synthase (ST8SIA1) in triple negative breast cancer-stem like cells |
| Funding Source: | Emerson Collective |
| Role: | CO-I |
| ID: | FP00008237 |
| Date: | 2019 - 2021 |
| Title: | Targeted sequencing methylation and ultra-deep sequencing of plasma cell-free DNA for early detection of MPNST in patients with neurofibromatosis type I |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R21CA240854-01 |
| Date: | 2019 - 2024 |
| Title: | Novel Combinatorial Strategies Aimed at Critical Drivers of Thyroid Cancer |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 1R01CA240837-01 |
| Date: | 2019 - 2020 |
| Title: | Targeting Immune Checkpoint Protein B7-H3 (CD276) in AML Using Novel Monoclonal Antibodies |
| Funding Source: | Leukemia Research Foundation |
| Role: | Biostatistician |
| ID: | FP00007825 |
| Date: | 2019 - 2023 |
| Title: | Targeting GD3 synthase (ST8SIA1) in GD2+ breast cancer stem-like cells to prevent tumor growth and metastases in triple negative breast cancer |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | BC181493 |
| Date: | 2019 - 2024 |
| Title: | Probing a glucose-dependent activation of the chromatin repressive NuRD complex for cancer therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA236807-01 |
| Date: | 2019 - 2019 |
| Title: | Role of KMT2D mutation in modulation of immune microenvironment in melanoma |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Collaborator |
| ID: | FP00003823_Res2 |
| Date: | 2019 - 2024 |
| Title: | Defining the Therapeutic Efficacy of miR-27a* in Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01DE028601-01 |
| Date: | 2019 - 2021 |
| Title: | Targeting immune checkpoint protein B7-H3 (CD276) in acute myeloid leukemia |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 1R21CA238088-01 |
| Date: | 2019 - 2024 |
| Title: | Mechanistic Study of DNA Repair Defect in Renal Cell Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA236963-01 |
| Date: | 2019 - 2022 |
| Title: | Probing a glucose-dependent activation of the chromatin repressive NuRD complex for cancer therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | FP00005453 |
| Date: | 2019 - 2022 |
| Title: | Role of H3K4 Methylation and LoxI2 in Resistance to Immune Checkpoint Blockade Agents in Melanoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | FP00005599 |
| Date: | 2019 - 2022 |
| Title: | GD3 Synthase (ST8SIA1) as a novel target in triple-negative breast cancer stem-like cells |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | FP00005801 |
| Date: | 2019 - 2020 |
| Title: | Targeting ST8SIA1 in breast cancer stem-like cells in TNBC |
| Funding Source: | Breast Cancer Alliance |
| Role: | Significant Contributor |
| ID: | FP00006133 |
| Date: | 2019 - 2021 |
| Title: | Noninvasive biomarkers for detection of NF1-associated MPNSTs using DNA methylation profiles of circulating tumor DNA |
| Funding Source: | US Department of Defense |
| Role: | Biostatistician |
| ID: | FP00006233 |
| Date: | 2019 - 2019 |
| Title: | Exploring anti-B7-H3 (CD276) chimeric antibodies in acute myeloid leukemia immunotherapy |
| Funding Source: | Elsa U Pardee Foundation |
| Role: | Biostatistician |
| ID: | FP00006353 |
| Date: | 2019 - 2022 |
| Title: | Role of KMT2D mutants in modulation of RA signaling and microenvironment |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Collaborator |
| ID: | FP00003823_Res1 |
| Date: | 2019 - 2021 |
| Title: | Targeting GD3 synthase (ST8SIA1) in GD2+ breast cancer stem-like cells to prevent tumor growth and metastases in triple negative breast cancer |
| Funding Source: | US Department of Defense |
| Role: | CO-I |
| ID: | FP00005664 |
| Date: | 2018 - 2021 |
| Title: | Accounting for and harnessing RBE variability in proton therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA225961-01A1 / FP2560_Res1 |
| Date: | 2018 - 2023 |
| Title: | Dietary Lipid-Driven Metabolic Reprogramming in Early Prostate Cancer |
| Funding Source: | National Institute Health / National Institute of Minority Health and Disease |
| Role: | Collaborator |
| ID: | 1R01MD013758-01 |
| Date: | 2018 - 2022 |
| Title: | Understanding Graft vs. Host Disease following Post-Transplant Immune Checkpoint Blockade |
| Funding Source: | Subaward Via University North Carolina-Chapel Hill |
| Role: | Bioinformatics |
| ID: | FP00005318 |
| Date: | 2018 - 2019 |
| Title: | Development of a clinical trial to assess an intestinal microbiome intervention for prophylaxis of acute gastrointestinal graft-versus-host disease |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 1U34HL144212-01 / FP00004517 |
| Date: | 2018 - 2019 |
| Title: | Adoptive Transfer of TGF-b resistant TIL to defeat immunosuppressive PDAC |
| Funding Source: | Stand Up To Cancer |
| Role: | CO-I |
| ID: | SU2C-AACR-PCC-03-18 |
| Date: | 2018 - 2019 |
| Title: | Targeting Breast Cancer Stem Cells |
| Funding Source: | BREAST CANCER RESEARCH FOUNDATION |
| Role: | Biostatistician |
| ID: | BCRF-18-007 |
| Date: | 2018 - 2020 |
| Title: | Targeting B7-H3 (CD276)-mediated immunomodulatory function in AML using novel monoclonal antibodies |
| Funding Source: | MDACC Emerson Collective Fund |
| Role: | Statistician |
| ID: | 600411-80-121462-19 |
| Date: | 2018 - 2023 |
| Title: | Modulating Anti-Leukemia Immunity Using Post-Transplant Immune Checkpoint Blockade |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | /1R01CA234261-01 / FP00004736 |
| Date: | 2018 - 2021 |
| Title: | Blood-based MRPS30 autoantibodies as a novel biomarker for early detection of ER-positive breast cancer |
| Funding Source: | US Department of Defense |
| Role: | CO-I |
| ID: | FP00005546 |
| Date: | 2018 - 2023 |
| Title: | Molecular Photoacoustic Imaging for Cancer Diagnostics and Therapy Monitoring |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA235563-01 |
| Date: | 2018 - 2023 |
| Title: | Clinical Trial of Targeting the Microbiome to Reduce Acute Intestinal GVHD |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01HL141883-01 |
| Date: | 2018 - 2023 |
| Title: | Investigating leukemia-osteogenic niche interactions in AML progression |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA234179-01 |
| Date: | 2018 - 2023 |
| Title: | ST8SIA1 as a novel target for triple-negative breast cancer stem-like cells |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA222639-01A1 / FP00001447_Res1 |
| Date: | 2018 - 2021 |
| Title: | Collaborative Research: Bayesian Network Estimation across Multiple Sample Groups and Data Types |
| Funding Source: | National Science Foundation |
| Role: | PI |
| ID: | 7827198 |
| Date: | 2018 - 2022 |
| Title: | Accounting for and harnessing RBE variability in proton therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5 R01 CA225961-03 |
| Date: | 2018 - 2021 |
| Title: | ST8SIA1 as a novel target in triple negative breast cancer |
| Funding Source: | National Science Foundation (NSF) |
| Role: | Statistician |
| ID: | FP00004751 |
| Date: | 2018 - 2019 |
| Title: | Identifying and Targeting DNA Damage Response Deficiency in Clear Cell Renal Cell Carcinoma |
| Funding Source: | Kidney Cancer Association |
| Role: | CO-I |
| ID: | FP00004952 |
| Date: | 2018 - 2023 |
| Title: | Improving decision-making in patients with rheumatoid arthritis and concomitant cancer |
| Funding Source: | NIH/AR |
| Role: | Other Significant Contributor |
| ID: | 1K01AR074143-01 / FP00003779 |
| Date: | 2018 - 2023 |
| Title: | Loxl2 and H3K4 methylation as effectors of anti-PD1 response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA231146-01A1/FP00003940_Res1 |
| Date: | 2018 - 2021 |
| Title: | Targeting ST8SIA1 in GD2+ breast cancer stem-like cells in prevention of triple negative breast cancer tumor growth and metastases |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | FP00004241 |
| Date: | 2018 - 2023 |
| Title: | Clinical Trial of Targeting the Microbiome to Reduce Acute Intestinal GVHD |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1 R01 HL141883 01 |
| Date: | 2018 - 2023 |
| Title: | Translational Biology and Biostatistics Core: Biology and exploitation of molecular drivers of renal cell cancer malignant progression |
| Funding Source: | Subaward from Stanford University |
| Role: | CO-I |
| ID: | P01 CA160728 |
| Date: | 2018 - 2020 |
| Title: | Detection of early stage breast cancer in high-risk women using autoantibodies |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1 R21 CA226324-01 |
| Date: | 2018 - 2021 |
| Title: | Circulating Exosomes as Biomarkers for Lung Cancer Early Detection |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP180505 |
| Date: | 2018 - 2022 |
| Title: | Circulating Exosomes as Biomarkers for Lung Cancer Early Detection |
| Funding Source: | American Cancer Society (ACS) |
| Role: | CO-I |
| ID: | ACS129099 |
| Date: | 2018 - 2021 |
| Title: | Targeting the KRAS mutant cancer cells by inducing a redox-dependent nuclear condensation |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | FP00002407 |
| Date: | 2018 - 2022 |
| Title: | Host immune and inflammatory biomarkers predict toxicity and efficacy of radiotherapy for breast cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP180386 |
| Date: | 2018 - 2021 |
| Title: | Evaluation of benefit/risk ratios and optimization of mammography screening that account for enhanced carcinogenic effectiveness of low energy x- rays |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP180068 |
| Date: | 2018 - 2021 |
| Title: | The Osteogenic Niche in Acute Myeloid Leukemia Progression |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Statistician |
| ID: | FP00002574 |
| Date: | 2018 - 2022 |
| Title: | Treatment of Steroid Refractory Acute GI GVHD with Transplantation of Third-Party Donor Fecal Microbiota |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | FP00002817 |
| Date: | 2018 - 2019 |
| Title: | Lipidomics-based biomarkers for risk of progression in early prostate cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R21 CA223527-02 |
| Date: | 2018 - 2020 |
| Title: | Early ovarian cancer detection in patients with inherited germline BRCA1/2 mutations |
| Funding Source: | Ovarian Cancer Research Fund |
| Role: | Co-PI |
| ID: | FP00003105 |
| Date: | 2018 - 2018 |
| Title: | Detection of Early Stage Breast Cancer in High-Risk Women using Autoantibodies |
| Funding Source: | ELSA U PARDEE FOUNDATION |
| Role: | Other Professional |
| ID: | FP00003360 |
| Date: | 2017 - 2020 |
| Title: | Evaluation of the benefit/risk ratios and optimization of mammography screening guidelines that account for the enhanced carcinogenic effectiveness of low energy x-rays |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA222139-01 |
| Date: | 2017 - 2022 |
| Title: | Improving decision-making in patients with cancer and autoimmune disease considering immune checkpoint inhibition |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1 K01 CA222488-01 |
| Date: | 2017 - 2020 |
| Title: | Prognostic and Predictive Markers of Immunogenicity in Renal Cell Carcinoma. CA160728 |
| Funding Source: | Department of Defense (DOD) |
| Role: | CO-I |
| ID: | CA160728P1 |
| Date: | 2017 - 2022 |
| Title: | Biology and exploitation of molecular drivers of renal cell cancer malignant progression |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | P01 CA160728 |
| Date: | 2017 - 2019 |
| Title: | A Universal Test for Early Detection of Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | FP00001215 |
| Date: | 2017 - 2022 |
| Title: | Translational Biology and Biostatistics Core |
| Funding Source: | Stanford University-Subaward |
| Role: | CO-I |
| ID: | FP00001791 (Resubmission) |
| Date: | 2017 - 2022 |
| Title: | ST8SIA1 as a novel target for triple-negative breast cancer stem-like cells |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA222639-01 |
| Date: | 2017 - 2022 |
| Title: | Probing a glucose-dependent activation of the class I HDACs for cancer therapy |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1R01CA214492-01 |
| Date: | 2017 - 2020 |
| Title: | Improving dose coverage of tumor radiotherapy of lung cancer through the use of flattening filter free beams |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R03CA211143-02 |
| Date: | 2017 - 2021 |
| Title: | Correcting Dose Calculation Errors in Radiation Oncology |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 5R01CA214526-04 |
| Date: | 2016 - 2020 |
| Title: | Optimizing Chemoradiation Strategies by Tumor Metabolism Interrogation |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP170366 |
| Date: | 2016 - 2020 |
| Title: | Chronic Lymphocytic Leukemia (CLL) - Immunotherapy |
| Funding Source: | The University of Texas MD Anderson Cancer Center Moon Shot |
| Role: | Statistician |
| ID: | 710499-80-111996-21 |
| Date: | 2016 - 2022 |
| Title: | Pathogenesis and Early Progression of Lung Cancer - Core 2: Biostatistics and Computational Biology |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP160668 |
| Date: | 2016 - 2022 |
| Title: | Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis |
| Funding Source: | NIH/NIDCR |
| Role: | CO-I |
| ID: | 5R01DE025248-05 |
| Date: | 2015 - 2025 |
| Title: | Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 5R01HL124112-08 |
| Date: | 2014 - 2025 |
| Title: | Imaging and Radiation Oncology Core (IROC) Group-Carbon Ion Supplement |
| Funding Source: | NIH/NCI subaward via American College of Radiology |
| Role: | Biostatistician |
| ID: | 5U24CA180803-07 |
| Date: | 2013 - 2017 |
| Title: | Genetic regulation of gene expression and its impact on phenotypes |
| Funding Source: | NIH/NIMH |
| Role: | Postdoctoral Fellow |
| ID: | 5R01MH101782-03 |
Selected Publications
Peer-Reviewed Articles
- Edward, SS, Pollard-Larkin, JM, Balter, PA, Howell, RM, Peterson, CB, Kry, SF. IROC phantoms accurately detect MLC delivery errors. Journal of Applied Clinical Medical Physics 26(5):e70017, 2025. e-Pub 2025. PMID: 39967029.
- Saha S, Rehman L, Rehman A, Darbaniyan F, Weber DM, Becnel M, Gaballa MR, Thomas SK, Lee HC, Chang CC, Arora R, Menges M, Corallo S, Davila ML, Locke FL, Tanner MR, Neelapu SS, Shpall EJ, Flowers CR, Orlowski RZ, Jenq RR, Jain MD, Peterson CB, Hansen DK, Saini NY, Patel KK. Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel. Blood Advances, 2025. e-Pub 2025. PMID: 40198765.
- Wooten ZT, Pham M, Court LE, Peterson CB. Location smoothed Bayesian additive regression trees: a method for interpretable and robust quality assurance of organ contours in radiotherapy treatment planning. Journal of the Royal Statistical Society Series C: Applied Statistics:qlaf024, 2025.
- Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. Characterization of LiF TLD-100 in carbon ion beams for remote audits. Medical physics 52(3):1858-1866, 2025. e-Pub 2025. PMID: 39718203.
- Brooks FMD, Glenn MC, Hernandez V, Saez J, Pollard-Larkin JM, Peterson CB, Howell RM, Nelson CL, Clark CH, Kry SF. Is the Imaging Radiation Oncology Core head and neck credentialing phantom an effective surrogate for different anatomic sites?. International Journal of Radiation Oncology*Biology*Physics 121(3):811-821, 2025. e-Pub 2025. PMID: 39362313.
- Ren Y, Peterson CB, Vannucci M. Bayesian network-guided sparse regression with flexible varying effects. Biometrics 80(4):ujae111, 2024. e-Pub 2024. PMID: 39377518.
- Hayase E, Hayase T, Mukherjee A, Stinson SC, Jamal MA, Ortega MR, Sanchez CA, Ahmed SS, Karmouch JL, Chang CC, Flores II, McDaniel LK, Brown AN, El-Himri RK, Chapa VA, Tan L, Tran BQ, Xiao Y, Fan C, Pham D, Halsey TM, Jin Y, Tsai WB, Prasad R, Glover IK, Enkhbayar A, Mohammed A, Schmiester M, King KY, Britton RA, Reddy P, Wong MC, Ajami NJ, Wargo JA, Shelburne S, Okhuysen PC, Liu C, Fowler SW, Conner ME, Katsamakis Z, Smith N, Burgos da Silva M, Ponce DM, Peled JU, van den Brink MRM, Peterson CB, Rondon G, Molldrem JJ, Champlin RE, Shpall EJ, Lorenzi PL, Mehta RS, Martens EC, Alousi AM, Jenq RR. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe 32(9):1621-1636.e6, 2024. e-Pub 2024. PMID: 39214085.
- McCoy K, Marisetty S, Tan D, Jensen CT, Siewerdsen JH, Peterson CB, Ahmad M. Automatic vessel attenuation measurement for quality control of contrast-enhanced CT: Validation on the portal vein. Medical Physics 51(9):5954-5964, 2024. e-Pub 2024. PMID: 39031758.
- Leone, AO, Mohamed, AS, Fuller, C, Peterson, CB, Garden, AS, Lee, A, Mayo, LL, Moreno, AC, Reddy, JP, Hoffman, K, Niedzielski, JS, Court, LE, Whitaker, TJ. A visualization and radiation treatment plan quality scoring method for triage in a population-based context. Advances in Radiation Oncology 9(8):101533, 2024. e-Pub 2024. PMID: 38993196.
- Marquez B, Wooten ZT, Salazar RM, Peterson CB, Fuentes DT, Whitaker TJ, Jhingran A, Pollard-Larkin J, Prajapati S, Beadle B, Cardenas CE, Netherton TJ, Court LE. Analyzing the relationship between dose and geometric agreement metrics for auto-contouring in head and neck normal tissues. Diagnostics (Basel) 14(15), 2024. e-Pub 2024. PMID: 39125508.
- Ren Y, Osborne N, Peterson CB, DeMaster DM, Ewing-Cobbs L, Vannucci M. Bayesian varying-effects vector autoregressive models for inference of brain connectivity networks and covariate effects in pediatric traumatic brain injury. Human Brain Mapping 45(10):e26763, 2024. e-Pub 2024. PMID: 38943369.
- Glitza IC, Seo YD, Spencer CN, Wortman JR, Burton EM, Alayli FA, Loo CP, Gautam S, Damania A, Densmore J, Fairchild J, Cabanski CR, Wong MC, Peterson CB, Weiner B, Hicks N, Aunins J, McChalicher C, Walsh E, Tetzlaff MT, Hamid O, Ott PA, Boland GM, Sullivan RJ, Grossmann KF, Ajami NJ, LaVallee T, Henn MR, Tawbi HA, Wargo JA. Randomized placebo-controlled, biomarker-stratified phase Ib microbiome modulation in melanoma: impact of antibiotic preconditioning on microbiome and immunity. Cancer Discovery 14(7):1161-1175, 2024. e-Pub 2024. PMID: 38588588.
- Taylor PA, Mirandola A, Ciocca M, Hartzell S, Vai A, Alvarez P, Howell RM, Koay EJ, Peeler CR, Peterson CB, Kry SF. Technical note: Radiological clinical equivalence for phantom materials in carbon ion therapy. Medical Physics 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
- Taylor, PA, Hartzell, S, Mirandola, A, Ciocca, M, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. OSLD nanoDot characterization for carbon radiotherapy dosimetry. Physics in Medicine and Biology 69(11):115001, 2024. e-Pub 2024. PMID: 38663410.
- Mishra AK, Mahmud I, Lorenzi PL, Jenq RR, Wargo JA, Ajami NJ, Peterson CB. TARO: tree-aggregated factor regression for microbiome data integration. Bioinformatics 40(6):btae321, 2024. e-Pub 2024. PMID: 38788190.
- Jin, Y, Miyama, T, Brown, AN, Hayase, T, Song, X, Singh, A, Huang, L, Flores, I, McDaniel, LK, Glover, I, Halsey, T, Prasad, R, Chapa, V, Ahmed, SS, Zhang, J, Rai, K, Peterson, CB, Lizee, GA, Karmouch, J, Hayase, E, Molldrem, JJ, Chang, C, Tsai, W, Jenq, RR. Tsyn-seq: a T cell synapse–based antigen identification platform. Cancer Immunology Research 12(5):530-543, 2024. e-Pub 2024. PMID: 38363296.
- Brooks, FD, Glenn, MC, Hernandez, V, Saez, J, Mehrens, H, Pollard-Larkin, JM, Howell, RM, Peterson, CB, Nelson, CL, Clark, CH, Kry, SF. A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy. Journal of Applied Clinical Medical Physics 25(5):e14318, 2024. e-Pub 2024. PMID: 38427776.
- Peterson CB, Saha S, Do KA. Analysis of microbiome data. Annual Review of Statistics and Its Application 11(1):483-504, 2024. e-Pub 2024. PMID: 38962089.
- Manzano, JM, Sahar, H, Aldrich, J, Lu, M, Shoukier, M, Peterson, CB, Dickson, KB, Koom-Dadzie, K, Kheder, E, Franco Vega, M, Mohammed, AD, Muthu, M, Simbaqueba Clavijo, CA, Senechalle, MS, Brito-Dellan, N. Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service. Supportive Care in Cancer 32(3), 2024. e-Pub 2024. PMID: 38366007.
- Murphy, BR, Dailey Garnes, NM, Hwang, H, Peterson, CB, Garey, K, Okhuysen, PC. Increased prevalence of Clostridioides difficile infection among pediatric oncology patients. Pediatric Infectious Disease Journal 43(2):136-141, 2024. e-Pub 2024. PMID: 38134390.
- Zhang, L, San Valentin, ED, John, TM, Jenq, RR, Do, K, Hanna, EY, Peterson, CB, Reyes-Gibby, CC. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck. Cancer 130(1):150-161, 2024. e-Pub 2024. PMID: 37688396.
- Court, LE, Aggarwal, A, Jhingran, A, Naidoo, K, Netherton, T, Olanrewaju, A, Peterson, CB, Parkes, J, Simonds, H, Trauernicht, C, Zhang, L, Beadle, BM. Artificial intelligence-based radiotherapy contouring and planning to improve global access to cancer care. JCO Global Oncology 10, 2024. e-Pub 2024. PMID: 38484191.
- He, Y, Cazoulat, G, Wu, CC, Svensson, S, Almodovar-Abreu, L, Rigaud, B, McCollum, E, Peterson, CB, Wooten, Z, Rhee, DJ, Balter, PA, Pollard-Larkin, JM, Cardenas, CE, Court, LE, Liao, Z, Mohan, R, Brock, K. Quantifying the effect of 4-dimensional computed tomography–based deformable dose accumulation on representing radiation damage for patients with locally advanced non-small cell lung cancer treated with standard-fractionated intensity-modulated radiation therapy. International Journal of Radiation Oncology Biology Physics 118(1):231-241, 2024. e-Pub 2024. PMID: 37552151.
- Shi Y, Zhang L, Do KA, Jenq RR, Peterson CB. survivalContour: visualizing predicted survival via colored contour plots. Bioinformatics Advances 4(1):vbae105, 2024. e-Pub 2024. PMID: 39086987.
- Taiji, R, Cortes, A, Zaske, AM, Williams, ML, Dupuis, CJ, Tanaka, T, Nishiofuku, H, Chintalapani, G, Peterson, CB, Avritscher, R. Liver cancer vascularity driven by extracellular matrix stiffness. Investigative Radiology 58(12):894-902, 2023. e-Pub 2023. PMID: 37403975.
- Fahrmann, JF, Wasylishen, A, Pieterman, CR, Irajizad, E, Vykoukal, JV, Wu, R, Dennison, JB, Peterson, CB, Zhao, H, Do, K, Halperin, DM, Agarwal, SK, Blau, J, Jha, S, Rivero, JD, Nilubol, N, Walter, MF, Welch, JM, Weinstein, LS, Vriens, MR, Van Leeuwaarde, RS, Van Treijen, MJ, Valk, GD, Perrier, ND, Hanash, S, Katayama, H. Blood-based proteomic signatures associated with MEN1-related duodenopancreatic neuroendocrine tumor progression. The Journal of Clinical Endocrinology and Metabolism 108(12):3260-3271, 2023. e-Pub 2023. PMID: 37307230.
- Thompson, PA, Bazinet, A, Wierda, WG, Tam, CS, O'Brien, S, Saha, S, Peterson, CB, Plunkett, W, Keating, M. Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up. Blood 142(21):1784-1788, 2023. e-Pub 2023. PMID: 37595283.
- Swisher, EM, Rayes, N, Bowen, D, Peterson, CB, Norquist, BM, Coffin, T, Gavin, K, Polinsky, D, Crase, J, Bakkum-Gamez, JN, Blank, S, Munsell, M, Nebgen, D, Fleming, GF, Olopade, OI, Law, S, Zhou, A, Levine, DA, D'Andrea, AD, Lu, KH. Remotely delivered cancer genetic testing in the Making Genetic Testing Accessible (MAGENTA) trial. JAMA Oncology 9(11):1547-1555, 2023. e-Pub 2023. PMID: 37707822.
- Gronberg, M, Jhingran, A, Netherton, T, Gay, SS, Cardenas, CE, Chung, CV, Fuentes, DA, Fuller, CD, Howell, RM, Khan, M, Lim, TY, Marquez, B, Olanrewaju, A, Peterson, CB, Vazquez, I, Whitaker, TJ, Wooten, ZT, Yang, M, Court, LE. Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Medical Physics 50(11):6639-6648, 2023. e-Pub 2023. PMID: 37706560.
- Witt, RG, Cass, SH, Tran, T, Damania, A, Nelson, EE, Sirmans, E, Burton, EM, Chelvanambi, M, Johnson, S, Tawbi, H, Gershenwald, JE, Davies, MA, Spencer, C, Mishra, A, Wong, MC, Ajami, NJ, Peterson, CB, Daniel-MacDougall, CR, Wargo, J, McQuade, JL, Nelson, KC. Gut microbiome in patients with early-stage and late-stage melanoma. JAMA Dermatology 159(10):1076-1084, 2023. e-Pub 2023. PMID: 37647056.
- Chien KS, Peterson CB, Young E, Chihara D, Manasanch EE, Ramdial J, Thompson PA. Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies. Blood Advances 7(19):5691-5697, 2023. e-Pub 2023. PMID: 36696472.
- Liu, X, Zhang, YT, McGrail, DJ, Zhang, X, Lam, TA, Hoang, A, Hasanov, E, Manyam, GC, Peterson, CB, Zhu, H, Kumar, SV, Akbani, R, Pilie, PG, Tannir, NM, Peng, G, Jonasch, E. SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical Cancer Research 29(19):4002-4015, 2023. e-Pub 2023. PMID: 37527013.
- Button, JE, Cosetta, CM, Reens, AL, Brooker, SL, Rowan-Nash, AD, Lavin, RC, Saur, R, Zheng, S, Autran, CA, Lee, ML, Sun, AK, Alousi, AM, Peterson, CB, Koh, AY, Rechtman, DJ, Jenq, RR, McKenzie, GJ. Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites. Cell Host and Microbe 31(9):1523-1538.e10, 2023. e-Pub 2023. PMID: 37657443.
- Ahmad, M, Sun, P, Peterson, CB, Anderson, M, Liu, X, Morani, A, Jensen, CT. Low pitch significantly reduces helical artifacts in abdominal CT. European Journal of Radiology 166, 2023. e-Pub 2023. PMID: 37481832.
- Thompson, PA, Keating, M, Ferrajoli, A, Jain, N, Peterson, CB, Garg, N, Wang, SA, Jorgensen, JL, Kadia, TM, Bose, P, Pemmaraju, N, Short, NJ, Wierda, WG. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia 37(7):1444-1453, 2023. e-Pub 2023. PMID: 37138019.
- Gordon, MJ, Jones, JE, George, B, Peterson, CB, Burger, JA, Jain, N, Keating, M, Wierda, WG, Durand, J, Ferrajoli, A. Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib. Cancer 129(14):2192-2200, 2023. e-Pub 2023. PMID: 37016930.
- Steenbeek, MP, Van Bommel, MH, Inthout, J, Peterson, CB, Simons, M, Roes, KC, Kets, M, Norquist, BM, Swisher, EM, Hermens, RP, Lu, KH, De Hullu, JA. TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention. International Journal of Gynecological Cancer 33(6):982-987, 2023. e-Pub 2023. PMID: 37045546.
- Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CE, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep learning-based dose prediction for automated, individualized quality assurance of head and neck radiation therapy plans. Practical Radiation Oncology 13(3):e282-e291, 2023. e-Pub 2023. PMID: 36697347.
- Mehrens H, Molineu A, Hernandez N, Court L, Howell R, Jaffray D, Peterson CB, Pollard-Larkin J, Kry SF. Characterizing the interplay of treatment parameters and complexity and their impact on performance on an IROC IMRT phantom using machine learning. Radiotherapy and Oncology 182:109577, 2023. e-Pub 2023. PMID: 36841341.
- Shoemaker, K, Ger, R, Court, LE, Aerts, HJ, Vannucci, M, Peterson, CB. Bayesian feature selection for radiomics using reliability metrics. Frontiers in Genetics 14(1112914), 2023. e-Pub 2023. PMID: 36968604.
- Zhou, Y, Medik, YB, Patel, B, Zamler, D, Chen, S, Chapman, T, Schneider, S, Park, EM, Babcock, R, Chrisikos, TT, Kahn, LS, Dyevoich, AM, Pineda, JE, Wong, MC, Mishra, A, Cass, SH, Cogdill, AP, Johnson, DH, Johnson, S, Wani, K, Ledesma, D, Hudgens, CW, Wang, JJ, Khan, MA, Peterson, CB, Joon, A, Peng, W, Li, H, Arora, R, Tang, X, Raso, G, Zhang, X, Foo, WC, Tetzlaff, M, Diehl, G, Dwyer, KC, Whitley, EM, Gubin, M, Allison, JP, Hwu, P, Ajami, NJ, Diab, A, Wargo, J, Watowich, SS. Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration. Journal of Experimental Medicine 220(2), 2023. e-Pub 2023. PMID: 36367776.
- Shi Y, Zhang L, Do K, Jenq RR, Peterson CB. Sparse tree-based clustering of microbiome data to characterize microbiome heterogeneity in pancreatic cancer. Journal of the Royal Statistical Society Series C: Applied Statistics 72(1):20-36, 2023. e-Pub 2023. PMID: 37034187.
- Francisco-Cruz A, Rocha P, Reuben A, Krishnan SN, Das P, Chen R, Quek K, Li J, Parra ER, Solis LM, Barua S, Jiang M, Lazcano R, Chow CW, Behrens C, Gumb C, Little L, Fukuoka J, Kalhor N, Weissferdt A, Kadara H, Heymach JV, Swisher S, Sepesi B, Rao A, Moran C, Zhang J, Lee JJ, Fujimoto J, Futreal PA, Wistuba II, Peterson CB, Zhang J. Analysis of immune intratumor heterogeneity highlights immunoregulatory and coinhibitory lymphocytes as hallmarks of recurrence in stage I non-small cell lung cancer. Mod Pathol 36(1), 2023. e-Pub 2023. PMID: 36788067.
- Francisco DMA, Zhang L, Jiang Y, Olvera A, Adachi J, Guevara EY, Aitken SL, Garey KW, Peterson CB, Do KA, Dillon R, Obi EN, Jenq R, Okhuysen PC. Risk factors associated with severe Clostridioides difficile infection in patients with cancer. Infectious Diseases and Therapy 12(1):209-225, 2023. e-Pub 2023. PMID: 36443547.
- Wooten ZT, Yu C, Court LE, Peterson CB. Predictive modeling using shape statistics for interpretable and robust quality assurance of automated contours in radiation treatment planning. Pacific Symposium on Biocomputing 2023 28:395-406, 2023. e-Pub 2023. PMID: 36540994.
- Das, P, Peterson, CB, Ni, Y, Reuben, A, Zhang, J, Zhang, J, Do, K, Baladandayuthapani, V. Bayesian hierarchical quantile regression with application to characterizing the immune architecture of lung cancer. Biometrics 79(3):2474-2488, 2023. e-Pub 2023. PMID: 36239535.
- Mendoza, TR, Hong, DS, Peterson, CB, Stephen, B, Ileana Dumbrava, EE, Pant, S, Tsimberidou, AM, Yap, TA, Sheshadri, A, Altan, M, George, GC, Castillo, L, Rodriguez, E, Gong, J, Subbiah, V, Janku, F, Fu, S, Piha-Paul, SA, Rodon Ahnert, J, Karp, DD, Cleeland, C, Meric-Bernstam, F, Naing, A. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II clinical trial. Scientific Reports 12(1), 2022. e-Pub 2022. PMID: 35999229.
- de Miguel-Perez, D, Russo, A, Arrieta, O, Ak, M, Barrón, F, Gunasekaran, M, Mamindla, P, Lara-Mejia, L, Peterson, CB, Er, ME, Peddagangireddy, V, Buemi, F, Cooper, B, Manca, P, Lapidus, RG, Hsia, RC, Cardona, AF, Naing, A, Kaushal, S, Hirsch, F, Mack, PC, Serrano, MJ, Adamo, V, Colen, R, Rolfo, C. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer. Journal of Experimental and Clinical Cancer Research 41(1), 2022. e-Pub 2022. PMID: 35650597.
- Schwabkey, Z, Wiesnoski, DH, Chang, C, Tsai, W, Pham, D, Ahmed, SS, Hayase, T, Ortega Turrubiates, MR, El-Himri, RK, Sanchez, CA, Hayase, E, Frenk Oquendo, AC, Miyama, T, Halsey, T, Heckel, BE, Brown, AN, Jin, Y, Raybaud, M, Prasad, R, Flores, I, McDaniel, L, Chapa, V, Lorenzi, PL, Warmoes, MO, Tan, L, Swennes, AG, Fowler, S, Conner, ME, McHugh, K, Graf, T, Jensen, VB, Peterson, CB, Do, K, Zhang, L, Shi, Y, Wang, Y, Galloway-Pena, J, Okhuysen, PC, Daniel-MacDougall, CR, Shono, Y, Burgos da Silva, M, Peled, JU, Van Den Brink, MR, Ajami, NJ, Wargo, J, Reddy, P, Valdivia, RH, Davey, L, Rondon, G, Srour, S, Mehta, RS, Alousi, AM, Shpall, E, Champlin, RE, Shelburne, S, Molldrem, JJ, Jamal, M, Karmouch, J, Jenq, RR. Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Science translational medicine 14(671):eabo3445, 2022. e-Pub 2022. PMID: 36383683.
- McCulloch, MM, Cazoulat, G, Svensson, S, Gryshkevych, S, Rigaud, B, Anderson, BM, Kirimli, E, De, BS, Mathew, R, Zaid, M, Elganainy, D, Peterson, CB, Balter, PA, Koay, EJ, Brock, K. Leveraging deep learning-based segmentation and contours-driven deformable registration for dose accumulation in abdominal structures. Frontiers in Oncology 12:1015608, 2022. e-Pub 2022. PMID: 36408172.
- Owens, CA, Rigaud, B, Ludmir, EB, Gupta, AC, Shrestha, S, Paulino, AC, Smith, SA, Peterson, CB, Kry, SF, Lee, C, Henderson, TO, Armstrong, GT, Brock, K, Howell, RM. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiotherapy and Oncology 176:118-126, 2022. e-Pub 2022. PMID: 36063983.
- Netherton, T, Nguyen, C, Cardenas, CE, Chung, C, Klopp, AH, Colbert, LE, Rhee, DJ, Peterson, CB, Howell, RM, Balter, PA, Court, LE. An automated treatment planning framework for spinal radiation therapy and vertebral-level second check. International Journal of Radiation Oncology Biology Physics 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
- Qi, X, Zhou, S, Wang, Y, Peterson, CB. Bayesian sparse modeling to identify high-risk subgroups in meta-analysis of safety data. Research Synthesis Methods 13(6):807-820, 2022. e-Pub 2022. PMID: 36054779.
- Coffin, T, Bowen, D, Swisher, EM, Lu, KH, Rayes, N, Norquist, BM, Blank, S, Levine, DA, Bakkum-Gamez, JN, Fleming, GF, Olopade, OI, D’Andrea, AD, Nebgen, D, Peterson, CB, Munsell, M, Gavin, K, Lechner, R, Crase, J, Polinsky, D, Romero, IL. An accessible communication system for population-based genetic testing: development and usability study. JMIR Formative Research 6(10):e34055, 2022. e-Pub 2022. PMID: 36251350.
- Das, P, De, D, Maiti, R, Jomaa, M, Hutcheson, KA, Fuller, C, Chakraborty, B, Peterson, CB. Estimating the optimal linear combination of predictors using spherically constrained optimization. BMC Bioinformatics 23(3):436, 2022. e-Pub 2022. PMID: 36261805.
- Barbon CE, Peterson CB, Moreno AC, Lai SY, Reddy JP, Sahli A, Martino R, Johnson FM, Fuller CD, Hutcheson KA. Adhering to eat and exercise status during radiotherapy for oropharyngeal cancer for prevention and mitigation of radiotherapy-associated dysphagia. JAMA Otolaryngology–Head & Neck Surgery 148(10):956-964, 2022. e-Pub 2022. PMID: 36074459.
- Thompson, PA, Jiang, XL, Banerjee, PP, Basar, R, Garg, N, Chen, K, Kaplan, M, Nandivada, V, Cortes, AN, Ferrajoli, A, Keating, M, Peterson, CB, Andreeff, M, Rezvani, K, Wierda, WG. A phase two study of high dose blinatumomab in Richter’s syndrome. Leukemia 36(9):2228-2232, 2022. e-Pub 2022. PMID: 35941212.
- Coffin, T, Bowen, D, Lu, KH, Swisher, EM, Rayes, N, Norquist, BM, Blank, S, Levine, DA, Bakkum-Gamez, JN, Fleming, GF, Olopade, OI, Romero, IL, D'Andrea, A, Nebgen, D, Peterson, CB, Munsell, M, Gavin, K, Crase, J, Polinsky, D, Lechner, R. Using social media to facilitate communication about women’s testing. JMIR Formative Research 6(9):e35035, 2022. e-Pub 2022. PMID: 36155347.
- Barbon, CE, Yao, CM, Peterson, CB, Moreno, AC, Goepfert, RP, Johnson, FM, Chronowski, G, Fuller, C, Gross, N, Hutcheson, KA. Swallowing after primary TORS and unilateral or bilateral radiation for low- to intermediate-risk tonsil cancer. Otolaryngology - Head and Neck Surgery 167(3):484-493, 2022. e-Pub 2022. PMID: 34784256.
- Franklin, S, Aitken, SL, Shi, Y, Sahasrabhojane, P, Robinson, S, Peterson, CB, Daver, N, Ajami, NJ, Kontoyiannis, DP, Shelburne, S, Galloway-Pena, J. Oral and stool microbiome coalescence and its association with antibiotic exposure in acute leukemia patients. Frontiers in Cellular and Infection Microbiology 12, 2022. e-Pub 2022. PMID: 35433514.
- Vassiliev, ON, Peterson, CB, Chang, JY, Mohan, R. Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams. Journal of Radiotherapy in Practice 21(1):81-87, 2022. e-Pub 2022. PMID: 35401050.
- Shi Y, Zhang L, Peterson CB, Do KA, Jenq RR. Performance determinants of unsupervised clustering methods for microbiome data. Microbiome 10(1):25, 2022. e-Pub 2022. PMID: 35120564.
- Osborne, N, Peterson, CB, Vannucci, M. Latent network estimation and variable selection for compositional data via variational EM. Journal of Computational and Graphical Statistics 31(1):163-175, 2022. e-Pub 2022. PMID: 36776345.
- Glenn, MC, Brooks, FE, Peterson, CB, Howell, RM, Followill, DS, Pollard-Larkin, JM, Kry, SF. Photon beam modeling variations predict errors in IMRT dosimetry audits. Radiotherapy and Oncology 166:8-14, 2022. e-Pub 2022. PMID: 34748857.
- Schmiester, M, Maier, R, Riedel, R, Durek, P, Frentsch, M, Kolling, S, Mashreghi, MF, Jenq, RR, Zhang, L, Peterson, CB, Bullinger, L, Chang, HD, Na, IK. Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma. Gut Microbes 14(1):e2081475, 2022. e-Pub 2022. PMID: 35634713.
- Vassiliev, ON, Peterson, CB, Chang, JY, Mohan, R. Using FFF beams to improve the therapeutic ratio of lung SBRT. Journal of Radiotherapy in Practice 20(4):419-425, 2021. e-Pub 2021. PMID: 35330584.
- Spencer, C, McQuade, JL, Gopalakrishnan, V, McCulloch, JA, Vétizou, M, Cogdill, AP, Wadud Khan, MA, Zhang, X, White, MG, Peterson, CB, Wong, MC, Morad, G, Rodgers, TE, Badger, JH, Helmink, BA, Andrews, MC, Rodrigues, RR, Morgun, A, Kim, YS, Roszik, J, Hoffman, KL, Zheng, JL, Zhou, Y, Medik, YB, Kahn, LS, Johnson, S, Hudgens, CW, Wani, K, Gaudreau, PO, Harris, AL, Jamal, M, Baruch, EN, Perez-Guijarro, E, Day, CP, Merlino, G, Pazdrak, B, Lochmann, BS, Szczepaniak Sloane, RA, Arora, R, Anderson, JE, Zobniw, C, Posada, E, Sirmans, E, Simon, JM, Haydu, LE, Burton, EM, Wang, L, Dang, M, Dwyer, KC, Schneider, S, Chapman, T, Anang, NA, Duncan, S, Toker, J, Malke, J, Glitza, IC, Amaria, RN, Tawbi, H, Diab, A, Wong, MK, Patel, SP, Woodman, SE, Davies, MA, Ross, MI, Gershenwald, JE, Lee, JE, Hwu, P, Jensen, VB, Samuels, Y, Straussman, R, Ajami, NJ, Nelson, KC, Nezi, L, Petrosino, JF, Futreal, A, Lazar, A, Hu, J, Jenq, RR, Tetzlaff, M, Yan, Y, Garrett, WS, Huttenhower, C, Sharma, P, Watowich, SS, Allison, JP, Cohen, L, Trinchieri, G, Daniel-MacDougall, CR, Wargo, J. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
- Fahrmann JF, Wasylishen AR, Pieterman CRC, Irajizad E, Vykoukal J, Murage E, Wu R, Dennison JB, Krishna H, Peterson CB, Lozano G, Zhao H, Do KA, Halperin DM, Agarwal SK, Blau JE, Del Rivero J, Nilubol N, Walter MF, Welch JM, Weinstein LS, Vriens MR, van Leeuwaarde RS, van Treijen MJC, Valk GD, Perrier ND, Hanash SM. A blood-based polyamine signature associated with MEN1 duodenopancreatic neuroendocrine tumor progression. The Journal of Clinical Endocrinology & Metabolism 106(12):e4969–e4980, 2021. e-Pub 2021. PMID: 34318891.
- McGrail DJ, Pilié PG, Dai H, Lam TNA, Liang Y, Voorwerk L, Kok M, Zhang XH, Rosen JM, Heimberger AB, Peterson CB, Jonasch E, Lin SY. Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers. Science Translational Medicine 13(617):eabe6201, 2021. e-Pub 2021. PMID: 34705519.
- Lim B, Peterson CB, Davis A, Cho E, Pearson T, Liu H, Hwang M, Ueno NT, Lee J. ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells. Biomedicines 9(10):1410, 2021. e-Pub 2021. PMID: 34680527.
- Bogomolov, M, Peterson, CB, Benjamini, Y, Sabatti, C. Hypotheses on a tree: new error rates and testing strategies. Biometrika 108(3):575-590, 2021. e-Pub 2021. PMID: 36825068.
- Zhang, L, Shi, Y, Jenq, RR, Do, K, Peterson, CB. Bayesian compositional regression with structured priors for microbiome feature selection. Biometrics 77(3):824-838, 2021. e-Pub 2021. PMID: 32686846.
- He Y, Cazoulat G, Wu C, Peterson CB, McCulloch M, Anderson B, Pollard-Larkin J, Balter P, Liao Z, Mohan R, Brock K. Geometric and dosimetric accuracy of deformable image registration between average-intensity images for 4DCT-based adaptive radiotherapy for non-small cell lung cancer. Journal of Applied Clinical Medical Physics 22(8):156-167, 2021. e-Pub 2021. PMID: 34310827.
- Hartzell S, Guan F, Taylor P, Peterson CB, Taddei P, Kry S. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy. Physics in Medicine & Biology 66(15):155018, 2021. e-Pub 2021. PMID: 34252894.
- Olanrewaju A, Court LE, Zhang L, Naidoo K, Burger H, Dalvie S, Wetter J, Parkes J, Trauernicht CJ, McCarroll RE, Cardenas C, Peterson CB, Benson KRK, du Toit M, van Reenen R, Beadle BM. Clinical acceptability of automated radiation treatment planning for head and neck cancer using the radiation planning assistant. Practical Radiation Oncology 11(3):177-184, 2021. e-Pub 2021. PMID: 33640315.
- Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. Journal for Immunotherapy of Cancer 9(4):e001752, 2021. e-Pub 2021. PMID: 33849924.
- Hajjar J, Mendoza T, Zhang L, Fu S, Piha-Paul SA, Hong DS, Janku F, Karp DD, Ballhausen A, Gong J, Zarifa A, Peterson CB, Meric-Bernstam F, Jenq R, Naing A. Associations between the gut microbiome and fatigue in cancer patients. Scientific Reports 11(1):5847, 2021. e-Pub 2021. PMID: 33712647.
- Rigaud B, Anderson BM, Yu ZH, Gobeli M, Cazoulat G, Söderberg J, Samuelsson E, Lidberg D, Ward C, Taku N, Cardenas C, Rhee DJ, Venkatesan AM, Peterson CB, Court L, Svensson S, Löfman F, Klopp AH, Brock KK. Automatic segmentation using deep learning to enable online dose optimization during adaptive radiation therapy of cervical cancer. Int J Radiat Oncol Biol Phys 109(4):1096-1110, 2021. e-Pub 2021. PMID: 33181248.
- Zhang L, Shi Y, Do KA, Peterson CB, Jenq RR. ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries. BMC Bioinformatics 22(1):126, 2021. e-Pub 2021. PMID: 33731016.
- Ha, MJ, Kim, J, Galloway-Pena, J, Do, K, Peterson, CB. Compositional zero-inflated network estimation for microbiome data. BMC Bioinformatics 21:1-20, 2020. e-Pub 2020. PMID: 33371887.
- Netherton, T, Rhee, DJ, Cardenas, CE, Chung, C, Klopp, AH, Peterson, CB, Howell, RM, Balter, PA, Court, LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Medical Physics 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
- Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, Pan BF, Lorenzi PL, Hurd M, Mittendorf EA, Peterson CB, Javle M, Bristow C, Kim M, Tuveson DA, Hawke D, Kopetz S, Wolff RA, Hwu P, Maitra A, Roszik J, Yee C, Lizée G. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nature Communications 11(1):5332, 2020. e-Pub 2020. PMID: 33087697.
- Glenn, MC, Peterson, CB, Howell, RM, Followill, DS, Pollard-Larkin, JM, Kry, SF. Sensitivity of IROC phantom performance to radiotherapy treatment planning system beam modeling parameters based on community-driven data. Medical Physics 47(10):5250-5259, 2020. e-Pub 2020. PMID: 32677052.
- Mendoza T, Sheshadri A, Altan M, Hess K, George G, Stephen B, Castillo L, Rodriguez E, Gong J, Peterson CB, Rodon Ahnert J, Fu S, Piha-Paul SA, Pant S, Dumbrava E, Yap TA, Janku F, Tsimberidou AM, Subbiah V, Karp DD, Zarifa A, McQuinn LM, Cleeland C, Hong DS, Naing A. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Journal for Immunotherapy of Cancer 8(2):e000931, 2020. e-Pub 2020. PMID: 33097611.
- Edward SS, Glenn M, Peterson CB, Balter PA, Pollard-Larkin JM, Howell RM, Followill D, Kry SF. Dose calculation errors as a component of failing IROC lung and spine phantom irradiations. Medical Physics 47(9):4502-4508, 2020. e-Pub 2020. PMID: 32452027.
- Vykoukal J, Fahrmann JF, Gregg JR, Tang Z, Basourakos S, Irajizad E, Park S, Yang G, Creighton CJ, Fleury A, Mayo J, Paulucci-Holthauzen A, Dennison JB, Murage E, Peterson CB, Davis JW, Kim J, Hanash S, Thompson TC. Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nature Communications 11(1):4279, 2020. e-Pub 2020. PMID: 32855410.
- Vassiliev ON, Peterson CB, Grosshans DR, Mohan R. A simple model for calculating relative biological effectiveness of X-rays and gamma radiation in cell survival. British Journal of Radiology 93(1112):20190949, 2020. e-Pub 2020. PMID: 32464080.
- McCulloch M, Cazoulat G, Ford A, Elgohari BA, Bahig H, Kim AD, Elhalawani HM, He R, Wang J, Ding Y, Mohamed ASR, Polan DF, King J, Peterson CB, Ohrt AN, Fuller CD, Lai SY, Brock KK. Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration. Phys Med Biol 65(16):165017, 2020. e-Pub 2020. PMID: 32320955.
- Galloway-Pena, J, Shi, Y, Peterson, CB, Sahasrabhojane, P, Gopalakrishnan, V, Brumlow, C, Daver, N, Alfayez, M, Boddu, P, Khan, MA, Wargo, J, Do, K, Jenq, RR, Kontoyiannis, DP, Shelburne, S. Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clinical Infectious Diseases 71(1):63-71, 2020. e-Pub 2020. PMID: 31436833.
- Shaddox E, Peterson CB, Stingo FC, Hanania NA, Cruickshank-Quinn C, Kechris K, Bowler R, Vannucci M. Bayesian inference of networks across multiple sample groups and data types. Biostatistics 21(3):561-576, 2020. e-Pub 2020. PMID: 30590505.
- Fahrmann JF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson CB, Katayama H, Disis ML, Arun B, Hanash S. Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer. Journal of the National Cancer Institute 112(6):607-616, 2020. e-Pub 2020. PMID: 31503278.
- Tinoco, M, Waga, E, Tran, K, Vo, H, Baker, JS, Hunter, R, Peterson, CB, Taku, N, Court, LE. RapidPlan development of VMAT plans for cervical cancer patients in low- and middle-income countries. Medical Dosimetry 45(2):172-178, 2020. e-Pub 2020. PMID: 31740042.
- Wu X, Park M, Sarbassova DA, Ying H, Lee MG, Bhattacharya R, Ellis L, Peterson CB, Hung MC, Lin HK, Bersimbaev RI, Song MS, Sarbassov DD. A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics. International Journal of Cancer 146(10):2822-2828, 2020. e-Pub 2020. PMID: 31472018.
- Liu XD, Kong W, Peterson CB, McGrail DJ, Hoang A, Zhang X, Lam T, Pilie PG, Zhu H, Beckermann KE, Haake SM, Isgandrova S, Martinez-Moczygemba M, Sahni N, Tannir NM, Lin SY, Rathmell WK, Jonasch E. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nature Communications 11(1):1-14, 2020. e-Pub 2020. PMID: 32358509.
- Rigaud, B, Cazoulat, G, Vedam, S, Venkatesan, AM, Peterson, CB, Taku, N, Klopp, AH, Brock, K. Modeling complex deformations of the sigmoid colon between external beam radiation therapy and brachytherapy images of cervical cancer. International Journal of Radiation Oncology Biology Physics 106(5):1084-1094, 2020. e-Pub 2020. PMID: 32029345.
- Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. Journal of the National Cancer Institute 112(3):266-277, 2020. e-Pub 2020. PMID: 31124563.
- Robinson, S, Peterson, CB, Sahasrabhojane, P, Ajami, NJ, Shelburne, S, Kontoyiannis, DP, Galloway-Pena, J. Observational cohort study of oral mycobiome and interkingdom interactions over the course of induction therapy for leukemia. mSphere 5(2), 2020. e-Pub 2020. PMID: 32295867.
- Das P, Peterson CB, Do KA, Akbani R, Baladandayuthapani V. NExUS: Bayesian simultaneous network estimation across unequal sample sizes. Bioinformatics 36(3):798-804, 2020. e-Pub 2020. PMID: 31504175.
- Chen CC, Shen TY, Peterson CB, Hung GU, Pan T. Comparison of ejection fraction calculation between CT and SPECT at high heart rate - a dynamic cardiac phantom study. Journal of Nuclear Cardiology 28(1):311-316, 2020. e-Pub 2020. PMID: 31907855.
- Shi Y, Zhang L, Do KA, Peterson CB, Jenq R. aPCoA: covariate adjusted principal coordinates analysis. Bioinformatics 36(13):4099-4101, 2020. e-Pub 2020. PMID: 32339223.
- Glenn, MC, Peterson, CB, Followill, DS, Howell, RM, Pollard-Larkin, JM, Kry, SF. Reference dataset of users’ photon beam modeling parameters for the Eclipse, Pinnacle, and RayStation treatment planning systems. Medical physics 47(1):282-288, 2020. e-Pub 2020. PMID: 31667870.
- Meier, J, Erasmus, JJ, Gladish, G, Peterson, CB, Diab, RH, Mawlawi, O. Characterization of continuous bed motion effects on patient breathing and respiratory motion correction in PET/CT imaging. Journal of applied clinical medical physics 21(1):158-165, 2020. e-Pub 2020. PMID: 31816183.
- Peterson CB, Osborne N, Stingo FC, Bourgeat P, Doecke JD, Vannucci M. Bayesian modeling of multiple structural connectivity networks during the progression of Alzheimer's disease. Biometrics 76(4):1120-1132, 2020. e-Pub 2020. PMID: 32026459.
- Edward SS, Alvarez PE, Taylor PA, Molineu HA, Peterson CB, Followill DS, Kry SF. Differences in the patterns of failure between IROC lung and spine phantom irradiations. Practical Radiation Oncology 10(5):372-381, 2020. e-Pub 2020. PMID: 32413413.
- Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, Shelburne S, Shah DP, Chambers MS, Hanna EY, Yeung SJ, Shete S. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer 126(23):5124-5136, 2020. e-Pub 2020. PMID: 32888342.
- Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson CB, Frank S, Followill D. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys 21(8):120-130, 2020. e-Pub 2020. PMID: 32506820.
- Cremaschi, A, Argiento, R, Shoemaker, K, Peterson, CB, Vannucci, M. Hierarchical normalized completely random measures for robust graphical modeling. Bayesian Analysis 14(4):1271-1301, 2019. e-Pub 2019. PMID: 32431780.
- Vassiliev, ON, Peterson, CB, Cao, W, Grosshans, DR, Mohan, R. Systematic microdosimetric data for protons of therapeutic energies calculated with Geant4-DNA. Physics in Medicine and Biology 64(21):215018, 2019. e-Pub 2019. PMID: 31553958.
- Rhee, DJ, Cardenas, CE, Elhalawani, H, McCarroll, RE, Zhang, L, Yang, J, Garden, AS, Peterson, CB, Beadle, BM, Court, LE. Automatic detection of contouring errors using convolutional neural networks. Medical physics 46(11):5086-5097, 2019. e-Pub 2019. PMID: 31505046.
- McCulloch, MM, Anderson, BM, Cazoulat, G, Peterson, CB, Mohamed, AS, Volpe, S, Elhalawani, H, Bahig, H, Rigaud, B, King, JB, Ford, AC, Fuller, C, Brock, K. Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer images. Physics in Medicine and Biology 64(17):175018, 2019. e-Pub 2019. PMID: 31269475.
- Riquelme Sanchez, EM, Zhang, Y, Zhang, L, Montiel, MF, Zoltan, M, Dong, W, Quesada, PR, Sahin, I, Chandra, V, San Lucas, FA, Scheet, PA, Xu, H, Hanash, S, Feng, L, Burks, JK, Do, K, Peterson, CB, Nejman, D, Tzeng, CD, Kim, M, Sears, CL, Ajami, NJ, Petrosino, JF, Wood, LD, Maitra, A, Straussman, R, Katz, MH, White, JR, Jenq, RR, Wargo, J, McAllister, F. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178(4):795-806.e12, 2019. e-Pub 2019. PMID: 31398337.
- Kry, SF, Glenn, MC, Peterson, CB, Branco, D, Mehrens, H, Steinmann, A, Followill, DS. Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans. Medical Physics 46(8):3700-3708, 2019. e-Pub 2019. PMID: 31152568.
- Rayes, N, Bowen, D, Coffin, T, Nebgen, D, Peterson, CB, Munsell, M, Gavin, K, Lechner, R, Crase, J, Polinsky, D, Romero, IL, Blank, S, Levine, DA, Norquist, BM, Swisher, EM, Lu, KH. MAGENTA (Making Genetic testing accessible): A prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer 19(648), 2019. e-Pub 2019. PMID: 31266460.
- Galloway-Pena, J, Peterson, CB, Malik, FA, Sahasrabhojane, P, Shah, DJ, Brumlow, C, Carlin, LG, Chemaly, RF, Im, JS, Rondon, G, Felix, E, Veillon, L, Lorenzi, PL, Alousi, AM, Jenq, RR, Kontoyiannis, DP, Shpall, E, Shelburne, S, Okhuysen, PC. Fecal microbiome, metabolites, and stem cell transplant outcomes: A single-center pilot study. Open Forum Infectious Diseases 6(5), 2019. e-Pub 2019. PMID: 31065565.
- Kim J, Do KA, Ha MJ, Peterson CB. Bayesian inference of hub nodes across multiple networks. Biometrics 75(1):172-182, 2019. e-Pub 2019. PMID: 30051914.
- Thompson, PA, Srivastava, J, Peterson, CB, Strati, P, Jorgensen, JL, Hether, T, Keating, M, O'Brien, S, Ferrajoli, A, Burger, JA, Estrov, Z, Jain, N, Wierda, WG. Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy. Blood 134(22):1951-1959, 2019. e-Pub 2019. PMID: 31537528.
- Strati, P, Takahashi, K, Peterson, CB, Keating, M, Thompson, PA, Daver, N, Jain, N, Burger, JA, Estrov, Z, O'Brien, S, Kantarjian, HM, Wierda, WG, Futreal, A, Ferrajoli, A. Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL. Blood Advances 3(9):1533-1539, 2019. e-Pub 2019. PMID: 31076409.
- Jiang, ZD, Jenq, RR, Ajami, NJ, Petrosino, JF, Alexander, AA, Ke, S, Iqbal, T, Dupont, A, Muldrew, K, Shi, Y, Peterson, CB, Do, K, DuPont, HL. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection. PloS one 13(11), 2018. e-Pub 2018. PMID: 30388112.
- Rubinstein, A, Gay, SS, Peterson, CB, Kingsley, CV, Tailor, RC, Pollard-Larkin, JM, Melancon, AD, Followill, DS, Court, LE. Radiation-induced lung toxicity in mice irradiated in a strong magnetic field. PloS One 13(11):e0205803, 2018. e-Pub 2018. PMID: 30444887.
- Thompson, PA, Peterson, CB, Strati, P, Jorgensen, JL, Keating, M, O'Brien, S, Ferrajoli, A, Burger, JA, Estrov, Z, Jain, N, Kadia, TM, Borthakur, G, DiNardo, C, Daver, N, Jabbour, EJ, Wierda, WG. Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies. Leukemia 32(11):2388-2398, 2018. e-Pub 2018. PMID: 29769624.
- Owens, CA, Peterson, CB, Tang, C, Koay, EJ, Yu, W, Mackin, DS, Li, J, Salehpour, M, Fuentes, DA, Court, LE, Yang, J. Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer. PloS One 13(10), 2018. e-Pub 2018. PMID: 30286184.
- Vassiliev ON, Kry SF, Wang HC, Peterson CB, Chang JY, Mohan R. Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium. Physics in Medicine & Biology 63(19):195007, 2018. e-Pub 2018. PMID: 30189421.
- Kry, SF, Peterson, CB, Howell, RM, Izewska, J, Lye, J, Clark, CH, Nakamura, M, Hurkmans, C, Alvarez, PE, Alves, A, Bokulic, T, Followill, DS, Kazantsev, P, Leif, JL, Molineu, HA, Palmer, J, Smith, SA, Taylor, PA, Wesolowska, P, Williams, I. Remote beam output audits. Physics and Imaging in Radiation Oncology 7:39-44, 2018. e-Pub 2018. PMID: 31872085.
- Court, LE, Kisling, K, McCarroll, RE, Zhang, L, Yang, J, Simonds, H, du Toit, M, Trauernicht, C, Burger, H, Parkes, J, Mejia, M, Bojador, M, Balter, PA, Branco, D, Steinmann, A, Baltz, G, Gay, SS, Anderson, BM, Cardenas, CE, Jhingran, A, Shaitelman, SF, Bogler, O, Schmeller, K, Followill, DS, Howell, RM, Nelson, CL, Peterson, CB, Beadle, BM. Radiation planning assistant - A streamlined, fully automated radiotherapy treatment planning system. Journal of Visualized Experiments 2018(134), 2018. e-Pub 2018. PMID: 29708544.
- Shaddox, E, Stingo, F, Peterson, CB, Jacobson, S, Cruickshank-Quinn, C, Kechris, KJ, Bowler, R, Vannucci, M. A Bayesian approach for learning gene networks underlying disease severity in COPD. Statistics in Biosciences 10(1):59-85, 2018. e-Pub 2018. PMID: 33912251.
- McCarroll, RE, Beadle, BM, Balter, PA, Burger, H, Cardenas, CE, Dalvie, S, Followill, DS, Kisling, K, Mejia, M, Naidoo, K, Nelson, CL, Peterson, CB, Vorster, K, Wetter, J, Zhang, L, Court, LE, Yang, J. Retrospective validation and clinical implementation of automated contouring of organs at risk in the head and neck. Journal of Global Oncology 2018(4):1-11, 2018. e-Pub 2018. PMID: 30110221.
- Jasinska AJ, Zelaya I, Service SK, Peterson CB, Cantor RM, et al. Genetic variation and gene expression across multiple tissues and developmental stages in a non-human primate. Nature Genetics 49(12):1714-1721, 2017. e-Pub 2017. PMID: 29083405.
- Yang, F, Wang, J, Pierce, BL, Chen, L, Aguet, F, Ardlie, K, Cummings, BB, Gelfand, ET, Getz, G, Hadley, K, Handsaker, RE, Huang, KH, Kashin, S, Karczewski, KJ, Lek, M, Li, X, MacArthur, DG, Nedzel, JL, Nguyen, DT, Noble, MS, Segrè, AV, Trowbridge, CA, Tukiainen, T, Abell, NS, Balliu, B, Barshir, R, Basha, O, Battle, A, Bogu, GK, Brown, AA, Brown, CD, Castel, SE, Chiang, C, Conrad, DF, Cox, NJ, Damani, FN, Davis, JR, Delaneau, O, Dermitzakis, ET, Engelhardt, BE, Eskin, E, Ferreira, PG, Frésard, L, Gamazon, ER, Garrido-Martín, D, Gewirtz, AD, Gliner, G, Gloudemans, MJ, Guigi, R, Peterson, CB. Identifying cis-mediators for trans-eQTLs across many human tissues using genomic mediation analysis. Genome research 27(11):1859-1871, 2017. e-Pub 2017. PMID: 29021290.
- Saha A, Kim Y, Gewirtz ADH, Jo B, Gao C, McDowell IC, GTEx Consortium [including Peterson CB], Engelhardt BE, Battle A. Co-expression networks reveal the tissue-specific regulation of transcription and splicing. Genome Research 27(11):1843-1858, 2017. e-Pub 2017. PMID: 29021288.
- GTEx Consortium [including Peterson CB]. Genetic effects on gene expression across human tissues. Nature 550(7675):204-213, 2017. e-Pub 2017. PMID: 29022597.
- Brzyski D, Peterson CB, Sobczyk P, Candes E, Bogdan M, Sabatti C. Controlling the rate of GWAS false discoveries. Genetics 205(1):61-75, 2017. e-Pub 2017. PMID: 27784720.
- Peterson CB, Bogomolov M, Benjamini Y, Sabatti C. TreeQTL: hierarchical error control for eQTL findings. Bioinformatics 32(16):2556-8, 2016. e-Pub 2016. PMID: 27153635.
- Peterson CB, Service SK, Jasinska AJ, Gao F, Zelaya I, Teshiba TM, Bearden CE, Cantor RM, Reus VI, Macaya G, López-Jaramillo C, Bogomolov M, Benjamini Y, Eskin E, Coppola G, Freimer NB, Sabatti C. Characterization of expression quantitative trait loci in pedigrees from Colombia and Costa Rica ascertained for bipolar disorder. PLoS Genet 12(5):e1006046, 2016. e-Pub 2016. PMID: 27176483.
- Peterson CB, Stingo FC, Vannucci M. Joint Bayesian variable and graph selection for regression models with network-structured predictors. Statistics in Medicine 35(7):1017-31, 2016. e-Pub 2016. PMID: 26514925.
- Peterson CB, Bogomolov M, Benjamini Y, Sabatti C. Many phenotypes without many false discoveries: error controlling strategies for multitrait association studies: Error controlling strategies for multitrait association studies. Genetic Epidemiology 40(1):45-56, 2016. e-Pub 2016. PMID: 26626037.
- Peterson CB, Stingo FC, Vannucci M. Bayesian inference of multiple Gaussian graphical models. Journal of the American Statistical Association 110(509):159-174, 2015. e-Pub 2015. PMID: 26078481.
- Rembach A, Stingo FC, Peterson CB, Vannucci M, Do K, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD, The AIBL Research Group. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's Disease. Journal of Alzheimer's Disease 10(4):P796-P797, 2015. e-Pub 2015. PMID: 25613103.
- Cowley AW, Moreno C, Jacob HJ, Peterson CB, Stingo FC, Ahn KW, Liu P, Vannucci M, Laud PW, Reddy P, Lazar J, Evans L, Yang C, Kurth T, Liang M. Characterization of biological pathways associated with a 1.37 Mbp genomic region protective of hypertension in Dahl S rats. Physiological Genomics 46(11):398-410, 2014. e-Pub 2014. PMID: 24714719.
- Allen, GI, Peterson, CB, Vannucci, M, Maletić-Savatić, M. Regularized partial least squares with an application to NMR spectroscopy. Statistical Analysis and Data Mining 6(4):302-314, 2013. e-Pub 2013. PMID: 24511361.
- Swartz MD, Peterson CB, Lupo PJ, Wu X, Forman MR, Spitz MR, Hernandez LM, Vannucci M, Shete S. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One 8(1):e53475, 2013. e-Pub 2013. PMID: 23372658.
- Peterson, CB, Vannucci, M, Karakas, C, Choi, W, Ma, L, Maletić-Savatić, M. Inferring metabolic networks using the bayesian adaptive graphical lasso with informative priors. Statistics and its Interface 6(4):547-558, 2013. e-Pub 2013. PMID: 24533172.
Invited Articles
- Peterson CB, Stingo FC. Invited discussion of “On the prior and posterior distributions used in graphical modelling” by Marco Scutari. Bayesian Analysis 8(3):539-542, 2013. e-Pub 2013.
Review Articles
- Liu R, Qiao X, Shi Y, Peterson CB, Bush WS, Cominelli F, Wang M, Zhang L. Constructing phylogenetic trees for microbiome data analysis: A mini-review. Computational and Structural Biotechnology Journal 23:3859-3868, 2024. e-Pub 2024. PMID: 39554614.
- Kisling, K, Ger, R, Netherton, T, Cardenas, CE, Owens, CA, Anderson, BM, Lee, JS, Rhee, DJ, Edward, SS, Gay, SS, He, Y, David, SD, Yang, J, Nitsch, PL, Balter, PA, Urbauer, D, Peterson, CB, Court, LE, Dube, S. A snapshot of medical physics practice patterns. Journal of Applied Clinical Medical Physics 19(6):306-315, 2018. e-Pub 2018. PMID: 30272385.
Book Chapters
- Peterson CB, Stingo F. Bayesian estimation of single and multiple graphs. In: Handbook of Bayesian Variable Selection. Chapman and Hall/CRC, 2021.
- Peterson CB, Swartz MD, Shete S, Vannucci M. Bayesian model averaging for genetic association studies. In: Advances in Statistical Bioinformatics: Models and Integrative Inference for High-Throughput Data. Cambridge University Press, 208-223, 2013.
Letters to the Editor
- de Miguel-Perez, D, Ortega, FG, Tejada, RG, Martínez-Única, A, Peterson, CB, Russo, A, Gunasekaran, M, Cardona, AF, Amezcua, V, Lorente, JA, Expósito Hernández, J, Rolfo, C, Serrano, MJ. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer. Biomarker Research 11, 2023.
Patient Reviews
CV information above last modified June 10, 2025